DUANE READE INC
424B3, 1998-04-27
DRUG STORES AND PROPRIETARY STORES
Previous: STERLING WORLDWIDE CORP, 10QSB, 1998-04-27
Next: MANUFACTURED HOME COMMUNITIES INC, 424B2, 1998-04-27





<PAGE>

===============================================================================

 THIS PROSPECTUS IS FILED PURSUANT TO RULE 424(B)(3) OF THE SECURITIES ACT OF 
                                    1933. 






                            PROSPECTUS SUPPLEMENT 
                                      TO 
                      PROSPECTUS DATED FEBRUARY 9, 1998 





                               DUANE READE INC. 



                       9 1/4% SENIOR SUBORDINATED NOTES 
                                   DUE 2008 






   ATTACHED IS THE COMPANY'S ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR 
                           ENDED DECEMBER 27, 1997. 

===============================================================================
<PAGE>
===============================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C.
                                ---------------
                                   FORM 10-K

 [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and 
     Exchange Act of 1934 

For the fiscal year ended December 27, 1997.  Commission file number 333-41239 
                                ---------------
                               DUANE READE INC. 
            (Exact name of registrant as specified in its charter) 

              DELAWARE                               04-3164702 
  (State or other jurisdiction of        (IRS Employer Identification Number) 
   incorporation or organization)        

            DRI I INC.*               DELAWARE                   04-3166107 
            DUANE READE*              NEW YORK                   11-2731721 

* Guarantors with respect to the Company's 9 1/4% Senior Subordinated Notes 
  due 2008 

             440 NINTH AVENUE 
            NEW YORK, NEW YORK                               10001 
(Address of principal executive offices)                   (Zip Code) 

                                 (212) 273-5700
              (Registrant's telephone number, including area code)
                                ---------------
         SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: 

                                            NAME OF EACH EXCHANGE
           TITLE OF EACH CLASS              ON WHICH REGISTERED 
- -----------------------------------------   ------------------- 
Common Stock, $.01 par value per share      New York Stock Exchange, Inc. 
9 1/4% Senior Subordinated Notes due 2008   None. 
                                ---------------
         SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: 
                                    None. 

   Indicate by check mark whether the registrant: (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. Yes  [ ] No [X] 

   Indicate by check mark if disclosure of delinquent filers pursuant to Item 
405 of Regulation S-K is not contained herein, and will not be contained, to 
the best of registrant's knowledge, in definitive proxy or information 
statements incorporated by reference in Part III of this Form 10-K or any 
amendment to this Form 10-K.  [X] 

   The only class of voting securities of Duane Reade Inc. is its Common 
Stock, par value $.01 per share (the "Common Stock"). On March 23, 1998, the 
aggregate market value of the voting stock held by non-affiliates of the 
registrant was approximately $224.8 million. 
                                ---------------
   The number of shares of the Common Stock outstanding as of March 23, 1998: 
16,960,577 
                                ---------------
                     DOCUMENTS INCORPORATED BY REFERENCE 

   Certain exhibits as listed on the Exhibit Index and filed with 
registrant's registration statements on Form S-1 (Nos. 333-41239 and 
333-43313) under the Securities Act of 1933, as amended, are incorporated by 
reference into Part IV of this Form 10-K. 
===============================================================================
<PAGE>
                                    INDEX 

<TABLE>
<CAPTION>
                                                                                          PAGE 
                                                                                        -------- 
<S>                                                                                     <C>
PART I 
ITEM 1. Business .....................................................................      1 
ITEM 2. Properties ...................................................................      7 
ITEM 3. Legal Proceedings ............................................................      8 
ITEM 4. Submission of Matters to a Vote of Security Holders ..........................      8 

PART II 
ITEM 5. Market for Registrant's Common Equity and Related Stockholder Matters ........      9 
ITEM 6. Selected Financial Data ......................................................      9 
ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of 
        Operations ...................................................................     11 
ITEM 8. Financial Statements and Supplementary Data ..................................     17 
ITEM 9. Changes in and Disagreements With Accountants on Accounting and Financial 
        Disclosure ...................................................................     34 

PART III 
ITEM 10. Directors and Executive Officers of the Registrant ..........................     35 
ITEM 11. Executive Compensation ......................................................     37 
ITEM 12. Security Ownership of Certain Beneficial Owners and Management ..............     43 
ITEM 13. Certain Relationships and Related Transactions ..............................     44 

PART IV 
ITEM 14. Exhibits, Financial Statement Schedules, and Reports on Form 8-K ............     46 

SIGNATURES ...........................................................................     48 
</TABLE>

<PAGE>
                                    PART I 

ITEM 1. BUSINESS 

GENERAL 

   Duane Reade is the largest drugstore chain in New York City, based on 
sales volume, with 58 of its 67 stores located in Manhattan's high-traffic 
business and residential districts. The Company operates almost twice as many 
stores in Manhattan as its next largest competitor. Since opening its first 
store in 1960, the Company has successfully executed a marketing and 
operating strategy tailored to the unique characteristics of New York City, 
the largest and most densely populated market in the United States. According 
to Drug Store News, Duane Reade is the leading drugstore chain in the United 
States in terms of sales per square foot, at $1,010 per square foot in 1997, 
which was more than two times the national average for drugstore chains. For 
the fiscal year ended December 27, 1997, the Company had sales of $429.8 
million and EBITDA of $43.1 million, increases of 12.7% and 22.0%, 
respectively, over the 1996 fiscal year. For the fiscal year ended December 
27, 1997, the Company had a net loss of $14.7 million. 

   The Company enjoys strong brand name recognition in New York City, which 
it believes results from the Company's many locations in high-traffic areas 
of Manhattan and the 30 million shopping bags with the distinctive Duane 
Reade logo that the Company distributes annually. An independent survey 
conducted in 1996 indicated that approximately 84% of the people who live or 
work in Manhattan recognize the Duane Reade name, and seven out of ten 
shopped at a Duane Reade store in the past twelve months. The Company was 
also recently named "Regional Drug Store Chain of the Year" for 1997 by Drug 
Store News. 

   The Company has developed an operating strategy designed to capitalize on 
the unique characteristics of the New York City market, which include 
high-traffic volume, complex distribution logistics and high costs of 
occupancy, media advertising and personnel. The key elements of the Company's 
operating strategy are (i) everyday low price format and broad product 
offering, (ii) low cost operating structure supported by its high volume 
stores and low advertising and distribution costs and (iii) ability to design 
and operate its stores in a wide variety of sizes and layouts. 

   The Company believes that its everyday low price format and broad product 
offerings provide value and convenience for its customers and build customer 
loyalty. The Company's everyday low price format results in prices that the 
Company believes are lower, on average, than the prices offered by its 
competitors. 

   The Company is able to keep its operating costs relatively low due to its 
high per store sales volume, relatively low warehouse and distribution costs 
and relatively low advertising expenditures. The Company's high volume stores 
allow it to effectively leverage occupancy costs, payroll and other store 
operating expenses. The Company's two primary distribution facilities are 
located within five miles of all but one of its 67 stores and, combined with 
the rapid turnover of inventory in Duane Reade's stores, result in relatively 
low warehouse and distribution costs. The Company plans to move all of its 
distribution facilities to another, recently leased warehouse in mid-1998. 
See "--Company Operations." The Company's strong brand name recognition in 
New York City and everyday low price format allow the Company to minimize its 
use of costly media and print advertising and to rely instead on in-window 
displays and other less expensive promotional activities. 

   The Company has demonstrated its ability to successfully operate stores 
using a wide variety of store configurations and sizes, which the Company 
believes is necessary to succeed in the New York City market. For example, 
the size of the Company's stores ranges from 2,600 to 12,300 square feet, and 
it operates 29 bi-level stores. The Company believes that its flexibility in 
configuring stores provides its with a competitive advantage in securing 
locations for is new stores, as many of its competitors target more 
standardized spaces for their stores, which are more difficult to find in New 
York City. In addition, the Company's management team has extensive 
experience and knowledge of the New York City real estate market, allowing it 
to pursue attractive real estate opportunities. 

                                1           
<PAGE>
   The Company's predecessor was founded in 1960. In 1992, Bain Capital 
acquired the Company from its founders and, in June 1997, investment funds 
affiliated with DLJMBPII (as defined) acquired approximately 91.5% of the 
outstanding capital stock of the Company from Bain Capital and certain other 
selling securityholders. Since the 1992 acquisition, the Company has incurred 
net losses in each fiscal year. 

   In 1994 and 1995, the Company experienced rapid expansion, growing from 40 
stores to 59 stores. However, as a result of liquidity constraints and the 
need for improved inventory controls, the Company was forced to suspend its 
store expansion program in late 1995. In early 1996, a strengthened 
management team led by Anthony Cuti, the Company's new Chairman and Chief 
Executive Officer, took several measures to improve operations, including 
improving inventory controls and decreasing out-of-stock occurrences, 
creating a loss prevention function to control inventory shrink and 
continuing to invest in MIS. In 1997, the Company resumed its store expansion 
program, opening seven stores. During Mr. Cuti's tenure at the Company, 
EBITDA has increased by 60.2% from $26.9 million for the 52 weeks ended March 
29, 1996 to $43.1 million for the fiscal year ended December 27, 1997, and 
the Company experienced net losses of $19.8 million and $14.7 million for the 
52 weeks ended March 29, 1996 and the fiscal year ended December 27, 1997, 
respectively. Net loss before non-recurring charges for the fiscal year ended 
December 27, 1997 was $2.0 million. 

COMPANY OPERATIONS 

   Merchandising. Duane Reade's overall merchandising strategy is to provide 
the broadest selection of branded and private label drugstore products 
available in Manhattan and to sell them at everyday low prices. To further 
enhance customer service and loyalty, the Company attempts to maintain a 
consistent in-stock position in all merchandise categories. In addition to 
prescription and OTC drugs, the Company offers health and beauty aids, food 
and beverage items, tobacco products, cosmetics, housewares, hosiery, 
greeting cards, photofinishing, photo supplies, seasonal merchandise and 
other products. Health and beauty care products, including OTC drugs, 
represent the largest of the Company's product categories. Duane Reade 
drugstores offer a wide variety of brand name and private label products, 
including oral, skin and hair care products, bath supplies, vitamins and 
nutritional supplements, feminine hygiene products, family planning products 
and baby care products. Popular brands of health and beauty aids are given 
ample shelf space, and large sizes are offered, which the Company believes 
appeals to the value consciousness of many Manhattan consumers. Convenience 
items such as candy, snacks and seasonal goods are positioned near the check 
out registers to provide optimum convenience and stimulate impulse purchases 
for the customers while allowing the store employees to monitor those product 
categories that are particularly susceptible to inventory shrink. 

   In addition to the wide array of brand products offered in its stores, the 
Company offers its own private label products. Private label products provide 
customers with high-quality, lower priced alternatives to name brand products 
while generating higher gross profit margins than name brand products. These 
offerings also enhance Duane Reade's reputation as a value-oriented store. 
the Company currently offers approximately 400 private label products. In 
1997, these private label products accounted for approximately 4.6% of 
non-pharmacy sales. The Company believes that its strong brand image, 
reputation for quality and reliability in the New York City market, and its 
economies of scale in purchasing allow it to aggressively promote private 
label goods. 

   The Company has recently made efforts to increase the sales of certain 
high-margin items, such as cosmetics, greeting cards and photofinishing. 
Other merchandising initiatives completed during 1996 and 1997 include an 
expanded selection of seasonal merchandise, vitamins, nutrition products and 
baby accessories, particularly in stores located in residential areas. The 
Company believes there are additional opportunities to continue to refine and 
improve the merchandise mix in its stores. 

   The Company also offers same-day photofinishing services in all of its 
stores and has recently introduced one-hour photofinishing in three stores. 
In 1998, the Company expects to introduce one-hour photofinishing in seven to 
ten additional stores. Management believes that photofinishing services 
contribute significantly to sales of other merchandise categories because of 
customer traffic increases that result from the customer visiting a store 
twice, in order to drop off film and pick up the processed photos. 

                                2           
<PAGE>
   Pharmacy. The Company believes that its pharmacy business will continue to 
contribute significantly to the Company's growth. Management also believes 
that a larger and stronger pharmacy business will enhance customer loyalty 
and generate incremental customer traffic, which is expected to increase 
sales of Duane Reade's wide variety of OTC drugs and other non-pharmacy 
merchandise. Duane Reade's prescription drug sales (as reflected by same 
store pharmacy sales) grew by 24.6% in 1997 compared to 1996. Sales of 
prescription and OTC drugs represented approximately 40% of total sales in 
1997 as compared with 35% of total sales in 1996. Although the average number 
of prescriptions filled by Duane Reade per store per week has increased from 
640 in 1994 to 863 during 1997, the Company's average remains well below the 
industry chain store average of approximately 1,200, providing significant 
opportunity for continued pharmacy growth. The Company believes that the 
average number of prescriptions filled per week by it lags behind the 
industry average because of (i) the historically low penetration of Third 
Party Plans in the New York City area and (ii) the Company's concentration of 
stores in business areas, rather than residential areas. The Company believes 
continued pharmacy growth will also increase overall customer traffic and 
benefits its non-pharmacy sales. 

   The Company generally locates the pharmacy at the rear of the store in 
order to maximize the pharmacy customer's exposure to other categories of 
merchandise in the front of the store. Each pharmacy is staffed with a 
registered pharmacist and drug clerk at all times to ensure quick and high 
quality service. Each store carries a complete line of both branded and 
generic prescription drugs. In 1996, the Company began a program to upgrade 
the quality of its pharmacy service. The Company believes that this 
initiative has contributed to its strong growth in pharmacy sales and should 
continue to benefit the Company as customer loyalty builds in response to 
improved service levels. 

   In addition to customer service initiatives in its pharmacy business, the 
Company has remodeled or redesigned 16 of its pharmacies since the beginning 
of 1996. This remodeling, which has primarily involved updating the pharmacy 
counter area to allow pharmacists and customers to have more direct contact 
and providing a consultation and waiting area for customers, has not resulted 
in any significant reduction in total retail selling space. By improving the 
store layout and accessibility of the pharmacist and pharmacy area, the 
stores that have been remodeled have achieved strong growth in their pharmacy 
business. All stores opened since 1995 have the new pharmacy counter area 
design. The Company currently operates 24 such stores. The Company has also 
launched pharmacy marketing initiatives, such as home delivery and 
prescription-by-fax services, which it believes have contributed to the 
increased sales and customer loyalty of the pharmacy business. 

   The Company believes that its extensive network of conveniently located 
stores, strong local market position, pricing policies and reputation for 
high quality health care products and services provide it with a competitive 
advantage in attracting pharmacy business from individual customers as well 
as Third Party Plans. The percentage of the Company's total prescription drug 
sales attributable to Third Party Plans increased to approximately 74% in 
1997 from approximately 64% in 1996. Although gross margins on sales to Third 
Party Plans are generally lower than other prescription drug sales because of 
the highly competitive nature of pricing for this business and the purchasing 
power of Third Party Plans, management believes that the lower gross profit 
margins are offset by the higher volume of pharmacy sales to Third Party Plan 
customers allowing the Company to leverage other fixed store operating 
expenses. In addition, the Company believes that Third Party Plans generate 
additional general merchandise sales by increasing customer traffic in the 
stores. As of December 27, 1997, the Company had contracts with over 100 
Third Party Plans, including every major Third Party Plan in the Company 
market areas. 

   Another important component of the Company's pharmacy growth strategy is 
the continued acquisition of prescription files from independent pharmacies 
in market areas currently served by existing Company stores. In 1997, the 
Company purchased the prescription files of eight independent pharmacies for 
an aggregate total of $830,000, which generated approximately $7 million in 
revenues on an annualized basis. Independent pharmacists tend to have a 
higher proportion of customers that are not Third Party Plans, which provide 
the Company with incremental revenue and higher margin contribution. When 
appropriate, the Company will retain the services of the pharmacist, whose 
personal relationship with the customers generally maximizes the retention 
rate of the purchased file. Since 1995, the Company has 

                                3           
<PAGE>
experienced an estimated 80% customer retention rate with respect to 
prescription files acquired. Presently, there are approximately 1,400 
independent pharmacies in New York City, and the Company believes that these 
stores will provide additional acquisition opportunities in the future. 

   The Company's pharmacies employ computer systems that link all of the 
Company's pharmacies and enable them to provide customers with a broad range 
of services. The Company's pharmacy computer network profiles customer 
medical and other relevant information, supplies customers with information 
concerning their drug purchases for income tax and insurance purposes and 
prepares prescription labels and receipts. The computer network also 
expedites transactions with Third Party Plans by electronically transmitting 
prescription information directly to the Third Party Plan and providing 
on-line adjudication, which confirms at the time of sale customer 
eligibility, prescription coverage and pricing and co-payment requirements 
and automatically bills the respective plan. On-line adjudication reduces 
losses from rejected claims and eliminates a portion of the Company's 
paperwork for billing and collection of receivables and costs associated 
therewith. 

   Store Operations. The majority of the Company's stores are located in the 
business and residential areas of Manhattan, the most densely populated area 
in the United States. The Company's operations have been tailored to handle 
high-volume customer traffic. During 1997, an average Duane Reade store 
served approximately 2,500 customers per weekday, and 700 customers during 
each of the peak lunch and commuting periods of the day. Some of the 
Company's stores may operate up to 25 registers during peak demand periods. 

   Duane Reade stores range in size from 2,600 to 12,300 square feet, with an 
average of 6,900 square feet. The Company's stores are designed to facilitate 
customer movement and to minimize inventory shrink. The Company believes that 
its wide, straight aisles and well-stocked shelves allow customers to find 
merchandise easily and allow the store's employees (managers, security 
guards, cashiers and stock clerks) to effectively monitor customer behavior. 
The Company attempts to group merchandise logically in order to enable 
customers to locate items quickly and to stimulate impulse purchases. 

   In 1996, the Company began planogramming its stores by using a 
computerized space management system to design each store's layout and 
product displays. The system seeks to maximize productivity per square foot 
of selling space, maintain consistency in merchandising and reduce inventory 
levels. To date, 52 stores have been designed by the system. Management 
believes that the Company's remaining stores will be planogrammed by the end 
of the second quarter of 1998. As a result, the Company believes that it has 
yet to realize the full benefits from this system. 

   The Company establishes each store's hours of operation in an attempt to 
best serve customer traffic patterns and purchase habits and to optimize 
store labor productivity. Stores in Manhattan's business districts are 
generally open five days a week. In residential and appropriate 
business/shopping districts, stores are open six or seven days a week with a 
heavy emphasis on convenient, early morning and late evening openings. In 
1997, the Company had seven stores which were open 24 hours a day, 365 days a 
year. The Company intends to continue to identify stores in which extended 
operating hours would improve customer service and convenience and contribute 
to the Company's profitability. Each store is supervised by one store manager 
and one or more assistant store managers. Stores are supplied by deliveries 
from the Company's warehouses in Queens an average of three times a week, 
allowing the stores to maintain a high in-stock position, maximize store 
selling space and minimize inventory required to be held on hand. 

   The Company attempts to mitigate inventory shrink through (i) the 
employment of full time security guards in each store, (ii) use of a 
state-of-the-art Electronic Article Surveillance ("EAS") system that detects 
unremoved EAS tags on valuable or easily concealed merchandise and (iii) 
merchandise delivery and stocking during non-peak hours. Additionally, all 
store and warehouse employees are trained to monitor inventory shrink, and 
the Company uses outside consulting services to monitor employee behavior. 
Recently, the Company hired a full-time team of loss prevention professionals 
and established an anonymous call-in line to allow employees to report 
instances of theft. The Company also instituted ongoing audits of warehouse 
picking and receiving and an anonymous reward line for the reporting of 
theft. The Company believes that these programs have enabled it to control 
inventory shrink and will enable it to continue to do so. 

                                4           
<PAGE>
   Purchasing and Distribution. The Company purchases approximately 82% of 
its merchandise directly from manufacturers. The Company distributes 
approximately 84% of its merchandise through the Company's warehouses and 
receives direct-to-store deliveries for approximately 16% of its purchases. 
Direct-to-store deliveries are made for some pharmaceuticals, greeting cards, 
photofinishing, convenience foods and beverages. The Company purchases from 
over 1,000 vendors. The Company believes that there are ample sources of 
supply for the merchandise currently sold in its stores. The Company manages 
its purchasing through a combination of forward buying, national buying and 
vendor discount ("deal") buying in ways in which it believes maximizes its 
buying power. For example, the Company uses a computerized forecasting and 
investment program that is designed to determine optimal forward buying 
quantities before an announced or anticipated price increase has been 
implemented. By forward buying, the Company stocks up on regularly carried 
items when manufacturers temporarily reduce the cost of goods or when a price 
increase has been announced or is anticipated. 

   The Company currently operates two warehouses, which are located within 
five miles of all but one of its stores. The Company's primary warehouse 
contains approximately 150,000 square feet devoted to inventory. The Company 
believes that the close proximity of the warehouses to the stores allows the 
Company to supply the stores frequently, thereby minimizing inventory and 
maximizing distribution economies. The Company also owns a fleet of trucks 
and vans, which it uses for all deliveries from the warehouses to the stores. 

   In March 1998, the Company entered into a new long-term lease for a 
300,000 square foot distribution center in Long Island City, New York. The 
facility will approximately double in the Company's distribution capacity and 
is one mile away from the Company's current center. The new facility is 
scheduled to open in mid-year 1998 and will replace the existing warehouses. 

ADVERTISING AND PROMOTION 

   The Company regularly promotes key items at reduced retail prices during 
four-week promotional periods. Store windows and in-store signs are utilized 
to communicate savings and value to shoppers. Additionally, over 30 million 
bags with the highly recognizable Duane Reade logo are used by its customers 
each year, helping to promote the Company's name throughout New York City. 
The Company also utilizes full color circulars to announce new stores and 
heavily circulates them in local areas to attract customers. Typically, a new 
store sells one to two times its regular volume during a grand opening 
promotion, which generally lasts two to three weeks. The Company generally 
does not rely heavily on the use of print or broadcast media to promote its 
stores. Rather, because of its many high-traffic locations, the Company 
typically relies on in-window displays as its primary method of advertising. 
In 1997, the Company began using radio advertising. The radio advertising 
focuses on the Company's pharmacy business, highlighting services enhanced by 
the modern pharmacy computer system, pharmacist accessibility and enhanced 
convenience 

MANAGEMENT INFORMATION SYSTEMS 

   The Company currently has modern pharmacy and inventory management 
information systems. In 1996, the Company completed the installation of a 
host-based, modern pharmacy information system. The pharmacy system (PDX) has 
reduced the processing time for electronic reimbursement approval for 
prescriptions from Third Party Plan providers from 50 seconds to 7 seconds, 
and the inventory management systems (JDA merchandising and E3 replenishment) 
have allowed the Company to increase turns in the warehouse from 11 to 13 per 
year. In early 1997, the Company began the process of installing its point of 
sale (POS) systems in its stores,. The Company believes that these systems 
will better allow the Company to better control pricing, inventory and 
shrink, while maximizing the benefits derived from the other parts of its 
systems installation program. POS will also provide sales analysis that will 
enable the Company to improve labor scheduling, and will help optimize 
planogram design by allowing detailed analysis of stock-keeping unit sales. 
The installation of the Company's POS systems was completed in December 1997. 
Additionally, the Company has upgraded its financial reporting systems and 
installed local and wide area networks to facilitate the transfer of data 
between systems and from the stores to headquarters. 

                                5           
<PAGE>
   The Company has several computer software systems will require 
modification or upgrading to accommodate the year 2000 and thereafter. The 
Company believes that all systems can be changed by the end of 1999 and does 
not expect the cost of all the changes to be material to the Company's 
financial condition or results of operations. 

COMPETITION 

   The Company's stores compete on the basis of, among other things, 
convenience of location and store layout, product mix, selection, customer 
service and price. The New York City drugstore market is highly fragmented 
due to the complexities and costs of doing business in the most densely 
populated area of the country. The diverse labor pool, local customer needs 
and complex real estate market in New York City all favor regional chains and 
independents that are familiar with the market. Duane Reade's store format is 
tailored to meet all of these requirements and has proven successful in both 
the business and residential neighborhoods of Manhattan. 

   Because of the difficulties of operating in densely populated areas, the 
New York City drugstore market remains under-penetrated by national chains as 
compared to the rest of the country. Nationwide, approximately 74% of the 
drugstore market is controlled by chains, while in New York City that number 
is approximately 50%. There can be no assurance that such underpenetration 
will continue. 

   Duane Reade believes that it has significant competitive advantages over 
the approximately 1,400 independent drugstores in New York City, including 
purchasing economies of scale, centrally located warehouses that minimize 
store inventory and maximize selling space, a full line of in stock, brand 
name merchandise and a convenient store format. Major chain competitors in 
the New York City market include Rite-Aid, Genovese and CVS. 

GOVERNMENT REGULATION 

   Duane Reade's stores and its distribution facility are registered with the 
federal U.S. Drug Enforcement Agency and are subject to various state and 
local licensing requirements. Each of Duane Reade's pharmacies and 
pharmacists located in New York are licensed by the State of New York. The 
pharmacy and pharmacists employed at Duane Reade's store in Newark, New 
Jersey are licensed by the State of New Jersey. In addition, Duane Reade has 
been granted cigarette tax stamping licenses from the State of New York and 
from the City of New York which permit Duane Reade to buy cigarettes directly 
from the manufacturers and stamp the cigarettes themselves. Duane Reade's 
stores possess cigarette tax retail dealers licenses issued by the State of 
New York, the City of New York and the State of New Jersey. 

EMPLOYEES 

   As of December 27, 1997, Duane Reade had approximately 2,000 employees, 
almost all of whom were full-time. Approximately 1,800 of the Company's 2,000 
employees are represented by unions. Non-union employees include employees at 
corporate headquarters, employees at Duane Reade's personnel office and store 
management. The distribution facility employees are represented by the 
International Brotherhood of Teamsters, Chauffeurs and Warehousemen and 
Helpers of America, Local 815, and all store employees are represented by the 
Allied Trade Council. Duane Reade's three year contracts with these two 
unions expire on August 31, 1999 and August 31, 1998, respectively. Duane 
Reade believes that its relations with its employees are good. 

TRADEMARKS 

   The name "Duane Reade" and the "DR" logo are registered trademarks. The 
Company believes that it has developed strong brand awareness within the New 
York City area. As a result, the Company regards the Duane Reade logo as a 
valuable asset. 

                                6           
<PAGE>
ITEM 2. PROPERTIES. 

   As of December 27, 1997, the Company is operating stores in the following 
locations: 

<TABLE>
<CAPTION>
                      NO. OF STORES 
                    ----------------- 
<S>                 <C>
Manhattan, NY .....         58 
Brooklyn, NY ......          4 
Bronx, NY .........          2 
Queens, NY ........          2 
Newark, NJ ........          1 
                    ----------------- 
 Total ............         67 
</TABLE>

   Store leases are generally for 15 year terms. The average year of 
expiration for all the Company's leases is 2006. Lease rates are generally 
subject only to increases based on inflation, real estate tax increases or 
maintenance cost increases. The following table sets forth the lease 
expiration dates of the Company's leased stores over each of the next five 
years and thereafter. Of the stores with leases expiring in the next five 
years, six have renewal options. 

<TABLE>
<CAPTION>
 YEAR 
- -------------- 
<S>               <C>
1998...........    2 
1999...........    1 
2000...........    4 
2001...........    0 
2002...........    9 
Thereafter.....   51 
</TABLE>

   The Company owns a distribution facility and related land in Long Island 
City, New York. The building contains approximately 150,000 square feet of 
space, all of which is used for warehousing and distribution. The Company 
also leases a 50,000 square foot distribution facility in Maspeth, New York, 
which is approximately one mile from the Long Island City facility. In 
addition, the Company recently entered into a new long-term lease for a 
distribution facility in Long Island City, New York. The Company plans to 
dispose of its owned warehouse once operations are moved to the new facility 
in mid-1998. 

   The Company leases space for its corporate headquarters, which is located 
in Manhattan, New York. 

   The foregoing information contains certain forward looking statements that 
involve a number of risks and uncertainties. A number of facts could cause 
actual results, performance, achievements of the Company, or industry results 
to be materially different from any future results, performance or 
achievements expressed or implied by such forward-looking statements. These 
factors include, but are not limited to, the competitive environment in the 
drugstore industry in general and in the Company's specific market area; 
inflation, changes in costs of goods and services; economic conditions in 
general and in the Company's specific market areas; demographic changes; 
changes in prevailing interest rates and the availability of and terms of 
financing to fund the anticipated growth of the Company's business; liability 
and other claims asserted against the Company; changes in operation strategy 
or development plans; the ability to attract and retain qualified personnel; 
the significant indebtedness of the Company; labor disturbances; changes in 
the Company's acquisition and capital expenditure plans; and other factors 
referenced herein. In addition, such forward-looking statements are 
necessarily dependent upon assumptions, estimates and dates that may be 
incorrect or imprecise and involve known and unknown risks, uncertainties and 
other factors. Accordingly, any forward-looking statements included herein do 
not purport to be predictions of future events or circumstances and may not 
be realized. Forward-looking statements can be identified by, among other 
things, the use of forward-looking terminology such as "believes," "expects," 
"may," "will," "should," "seeks," "pro forma," "anticipates," "intends" or 
the negative of any thereof, or other variations thereon or comparable 
terminology, or by discussion of strategy or intentions. Given these 
uncertainties, prospective investors are cautioned not to place undue 
reliance on such forward-looking statements. The Company disclaims any 
obligations to update any such factors or to publicly announce the results of 
any revisions to any of the forward looking statements contained herein to 
reflect future events or developments. 

                                7           
<PAGE>
ITEM 3. LEGAL PROCEEDINGS 

   The Company is a party to certain legal actions arising in the ordinary 
course of business. Based on information presently available to the Company, 
the Company believes that it has adequate legal defenses or insurance 
coverage for these actions and that the ultimate outcome of these actions 
will not have a material adverse effect on the Company. 

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS 

   On November 24, 1997, a majority of the security holders of the Company 
approved the initial public offering of the Company's Common Stock, a change 
of the Company's name from Duane Reade Holding Corp. to Duane Reade Inc. and 
Anthony J. Cuti's Employment Agreement and Option Agreement (effective June 
18, 1997) by written consent in lieu of a meeting. On December 23, 1997, a 
majority of the security holders of the Company approved and ratified all 
employee stock options granted pursuant to the 1997 Equity Participation Plan 
by written consent in lieu of a meeting. 

                                8           
<PAGE>
                                   PART II 

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED 
        STOCKHOLDER MATTERS 

MARKET PRICE RANGE OF COMMON STOCK 

   Duane Reade's Common Stock is listed on the New York Stock Exchange under 
the symbol: "DRD". At March 23, 1998 there were 85 recordholders of the 
Common Stock. The Company's Common Stock was not publicly traded in 1997 and 
the Company paid no dividends. 

ITEM 6. SELECTED FINANCIAL DATA 
        (in thousands, except per share amounts, percentages and store data) 

<TABLE>
<CAPTION>
                                                                               FISCAL YEAR 
                                                      -------------------------------------------------------------- 
                                                          1997        1996         1995        1994         1993 
                                                      ----------- -----------  ----------- -----------  ----------- 
<S>                                                   <C>         <C>          <C>         <C>          <C>
STATEMENT OF OPERATIONS DATA: 
Net sales ...........................................   $429,816    $381,466     $336,922    $281,103     $241,474 
Cost of sales .......................................    322,340     288,505      259,827     209,678      181,566 
                                                      ----------- -----------  ----------- -----------  ----------- 
Gross profit ........................................    107,476      92,961       77,095      71,425       59,908 
Selling, general and administrative expenses ........     65,414      59,048       50,326      39,741       29,666 
Amortization ........................................      5,303      16,217       11,579      18,238       27,432 
Depreciation ........................................      3,507       3,015        1,929       1,184          729 
Store pre-opening expenses ..........................        767         139        1,095       1,220          300 
Nonrecurring charges (1) ............................     12,726          --           --          --           -- 
                                                      ----------- -----------  ----------- -----------  ----------- 
Operating income ....................................     19,759      14,542       12,166      11,042        1,781 
Net interest expense ................................     34,473      32,396       30,224      27,480       26,199 
                                                      ----------- -----------  ----------- -----------  ----------- 
Loss before taxes ...................................    (14,714)    (17,854)     (18,058)    (16,438)     (24,418) 
Provision for taxes .................................         --          --           --          --           -- 
                                                      ----------- -----------  ----------- -----------  ----------- 
Net loss ............................................   $(14,714)   $(17,854)    $(18,058)   $(16,438)    $(24,418) 
                                                      =========== ===========  =========== ===========  =========== 
Net loss per common share--basic ....................   $  (1.45)   $  (1.77)    $  (1.77)   $  (1.62)    $  (2.45) 
                                                      =========== ===========  =========== ===========  =========== 
Weighted average common shares 
 outstanding--basic..................................     10,161      10,103       10,178      10,161        9,976 
                                                      =========== ===========  =========== ===========  =========== 
OPERATING AND OTHER DATA: 
EBITDA (2) ..........................................   $ 43,056    $ 35,300     $ 27,443    $ 31,188     $ 29,975 
EBITDA as a percentage of sales .....................       10.0%        9.3%         8.2%       11.1%        12.4% 
Number of stores at end of period ...................         67          60           59          51           40 
Same store sales growth (3) .........................        7.6%        8.3%        (3.5)%       1.6%         3.3% 
Pharmacy same store sales growth (3)(5)..............       24.6%       25.5%         7.0%       14.2%          -- 
Average store size (square feet) at end of period ...      6,910       6,733        6,712       6,596        6,172 
Sales per square foot (4) ...........................   $  1,010    $    956     $    898    $    970     $  1,022 
Pharmacy sales as a % of net sales ..................       25.1%       21.8%        19.0%       17.6%        16.6% 
Third-Party Plan sales as of % of pharmacy sales 
 (5).................................................       74.2%       64.4%        58.2%       45.7%          -- 
Capital expenditures ................................   $ 13,493    $  1,247     $  6,868    $  9,947     $  1,838 
BALANCE SHEET DATA (AT END OF PERIOD): 
Working capital .....................................   $ 37,494    $  9,917     $ 13,699    $ 20,152     $ 14,285 
Total assets ........................................    249,521     222,476      235,860     229,699      234,430 
Total debt and capital lease obligations.............    278,085     245,657      244,104     228,764      223,422 
Stockholders' deficiency ............................    (74,109)    (59,396)     (41,196)    (23,170)      (6,757) 
</TABLE>

- ------------ 
(1)    Refer to Note 12 of Consolidated Financial Statements. 
(2)    As used herein, "EBITDA" means net loss plus nonrecurring charges, 
       interest, income taxes, depreciation, amortization and other non-cash 
       items (primarily deferred rents). Management believes that EBITDA, as 
       presented, represents a useful measure of assessing the performance of 
       the Company's ongoing operating activities as it reflects the earnings 
       trends of the Company without the impact of certain non-cash charges. 
       Targets and positive trends in EBITDA are used as the performance 
       measure for determining management's bonus compensation; EBITDA is also 
       utilized by the Company's creditors in assessing debt covenant 
       compliance. The Company understands that, while EBITDA is frequently 
       used by security analysis in the evaluation of companies, it is not 
       necessarily comparable to other similarly titled captions of other 
       companies due to potential inconsistencies in the method of 
       calculation. EBITDA is not intended as an alternative to cash flow from 
       operating activities as a measure of liquidity, nor an alternative to 
       net income as an indicator of the Company's operating performance nor 
       any other measure of performance in conformity with GAAP. 

                                9           
<PAGE>
       A reconciliation of net loss to EBITDA for each period included above 
       is set forth below (dollars in thousands): 

<TABLE>
<CAPTION>
                                                FISCAL YEAR 
                       -------------------------------------------------------------- 
                           1997        1996         1995        1994         1993 
                       ----------- -----------  ----------- -----------  ----------- 
   <S>                 <C>         <C>          <C>         <C>          <C>
   Net loss  .........   $(14,714)   $(17,854)    $(18,058)   $(16,438)    $(24,418) 
   Net interest 
   expense  ..........     34,473      32,396       30,224      27,480       26,199 
   Amortization  .....      5,303      16,217       11,579      18,238       27,432 
   Depreciation  .....      3,507       3,015        1,929       1,184          729 
   Nonrecurring 
   charges  ..........     12,726          --           --          --           -- 
   Other non-cash 
   items  ............      1,761       1,526        1,769         724           33 
                       ----------- -----------  ----------- -----------  ----------- 
   EBITDA  ...........   $ 43,056    $ 35,300     $ 27,443    $ 31,188     $ 29,975 
                       =========== ===========  =========== ===========  =========== 
</TABLE>

(3)    Same store sales figures include stores that have been in operation for 
       at least 13 months. 
(4)    The Company experienced a decline in sales per square foot from 1993 
       through 1995 as a result of the opening of additional stores in 
       connection with the Company's expansion. The opening of such additional 
       stores resulted in a decline in sales per square foot principally 
       because (i) the average square footage for the new stores was greater 
       than that of the existing store base and (ii) new stores generally take 
       some time to reach a mature level of sales. See "Management's 
       Discussion and Analysis of Financial Condition and Results of 
       Operations--General." 
(5)    Prior to fiscal year 1994, the Company's pharmacy system did not 
       separately track third-party sales. 

                               10           
<PAGE>
   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
                                RESULTS OF OPERATIONS. 

   The following should be read in connection with the consolidated financial 
statements of the Company and the notes thereto included elsewhere in this 
document. 

GENERAL 

   The Company generates revenues primarily through sales of OTC drugs and 
prescription pharmaceutical products, health and beauty aids, food and 
beverage items, tobacco products, cosmetics, housewares, hosiery, greeting 
cards, photofinishing, photo supplies and seasonal merchandise. Health and 
beauty products, including OTC drugs, represent the largest of the Company's 
product categories. The Company's primary costs and expenses consist of (i) 
inventory costs, (ii) labor expenses and (iii) occupancy costs. 

   In 1994 and 1995, the Company experienced rapid expansion, growing from 40 
stores to 59 stores. However, as a result of liquidity constraints and the 
need for improved inventory controls, the Company was forced to suspend its 
store expansion program in late 1995. In early 1996, a strengthened 
management team led by Anthony Cuti, the Company's new Chairman and Chief 
Executive Officer, took several measures to improve operations such as 
decreasing out-of stock occurrences, creating a loss prevention function to 
control inventory shrink and continuing to invest in MIS. 

   The Company had sales per square foot of $956 and $1,010 in fiscal 1996 
and fiscal 1997, respectively. The Company believes that sales per square 
foot are a useful measure of comparing the Company's performance to that of 
its competitors because it is a measure of a store's sales productivity. The 
Company experienced a decline in sales per square foot from 1993 through 1995 
as a result of the opening of additional stores in connection with the 
Company's expansion plans during that period. The opening of such additional 
stores resulted in a decline in sales per square foot principally because (i) 
the average square footage for the new stores was greater than that of the 
existing store base and (ii) new stores generally take some time to reach a 
mature level of sales. The Company currently expects that its sales per 
square foot may decline as it embarks on its plan to increase new store 
openings during 1998 and 1999. The Company believes that its competitors in 
the industry experience increases and decreases in sales per square foot for 
similar reasons. 

   In 1997, the Company resumed its store expansion program, opening seven 
stores. Generally a new Duane Reade store requires an investment of 
approximately $1.1 million in capital expenditures and working capital. Since 
1993, all of the Company's new stores have become profitable on an operating 
basis within the first full year of operation. Over the next two years, the 
Company plans to open approximately 30 to 40 stores, primarily in New York 
City. 

   Over the past two years, Third Party Plans, including managed care 
providers and insurance companies, have comprised an increasing percentage of 
the Company's pharmacy business as the health care industry shifts to managed 
care. While sales to customers covered by Third Party Plans results in lower 
gross profit rates due to competitive pricing, the Company believes that such 
lower rates are offset by increased volume of pharmacy sales and the 
opportunity to leverage fixed expenses. 

   The Company includes stores that have been in operation for at least 13 
months for purposes of calculating comparable store sales figures. 

   The Company's predecessor was founded in 1960. In 1992, Bain Capital 
formed the Company to acquire the Company's predecessor from its founders 
through a leveraged buyout, financed primarily with the proceeds from the 
Zero Coupon Notes and the Senior Notes. In June 1997, investment funds 
affiliated with DLJMBPII (the "DLJMB Entities"), an affiliate of DLJ, 
acquired approximately 91.5% of the outstanding capital stock of the Company 
from Bain Capital and certain other selling securityholders, for 
approximately $78.7 million in cash, pursuant to a Recapitalization 
Agreement, dated June 18, 1997 (the "Recapitalization Agreement"). Upon 
consummation of such purchase, the Company reclassified all of its 
outstanding capital stock (then consisting of four classes) into one class of 
common stock, $0.01 par value per share. 

                               11           
<PAGE>
   Prior to the consummation of the initial public offering in February 1998, 
the Company's primary asset was all of the outstanding common stock of 
Daboco, Inc., a New York corporation ("Daboco"), with Daboco and DRI I, Inc. 
("DRI"), a direct wholly-owned subsidiary of Daboco, together owning all of 
the outstanding partnership interest of Duane Reade, a New York general 
partnership ("Duane Reade") (Daboco owns a 99% partnership interest and DRI 
owns the remaining 1% partnership interest). Substantially all of the 
operations of the Company are conducted through Duane Reade. Concurrently 
with the consummation of the Offering, Daboco was merged with and into the 
Company (the "Merger"), resulting in the Company directly owning 99% of the 
partnership interests of Duane Reade (the "Partnership Interests") and DRI 
continuing to own a 1% partnership interest. Following the consummation of 
the Merger, the primary assets of the Company are the Partnership Interest 
and 100% of the outstanding common stock of DRI. 

RESULTS OF OPERATIONS 

   The following sets forth the results of operations as a percentage of 
sales for the periods indicated. 

<TABLE>
<CAPTION>
                                                       FISCAL YEAR 
                                               ---------------------------- 
                                                 1997      1996     1995 
                                               -------- --------  -------- 
<S>                                            <C>      <C>       <C>
Net Sales ....................................   100.0%   100.0%    100.0% 
Cost of Sales ................................    75.0     75.6      77.1 
                                               -------- --------  -------- 
Gross profit .................................    25.0     24.4      22.9 
                                               -------- --------  -------- 
Selling, general and administrative expenses      15.2     15.5      14.9 
Amortization .................................     1.2      4.3       3.5 
Depreciation .................................     0.8      0.8       0.6 
Store pre-opening expenses ...................     0.2      0.0       0.3 
Nonrecurring charges .........................     3.0       --        -- 
                                               -------- --------  -------- 
Operating income .............................     4.6      3.8       3.6 
Net interest expense .........................     8.0      8.5       9.0 
                                               -------- --------  -------- 
Net loss .....................................    (3.4)%   (4.7)%    (5.4)% 
                                               ======== ========  ======== 
</TABLE>

 FISCAL 1997 COMPARED TO FISCAL 1996 

   Net sales in 1997 were $429.8 million, an increase of 12.7% over 1996 net 
sales of $381.5 million. The increase was attributable to increased 
comparable store sales of 7.6% and the inclusion of one new store opened 
during 1996 for the entire 1997 period and seven new stores opened in 1997. 

   Cost of sales as a percentage of net sales decreased to 75.0% for 1997 
from 75.6% for 1996, resulting in an increase in gross profit margin to 25.0% 
for 1997 from 24.4% during 1996. The increase in gross margin resulted from a 
number of factors including (i) increased contribution from the sale of 
higher margin merchandise such as cosmetics, vitamins, general merchandise, 
generic drugs and private label products, (ii) higher promotional allowances 
received from venders and (iii) occupancy costs that increased at a lesser 
rate than the rate at which sales increased. 

   Selling, general and administrative expenses were $65.4 million or 15.2% 
of net sales and $59.0 million or 15.5% of net sales in 1997 and 1996, 
respectively. The percentage decrease in 1997 compared to 1996 resulted 
principally from lower general and administrative expense as a percentage of 
net sales including the elimination of agreements requiring the annual 
payment of $1.0 million in management fees to Bain Capital, partially offset 
by higher selling expenses related to higher store salaries as a percentage 
of net sales (principally from new stores during the early months of 
operation). The Company believes, that as the Company's new stores mature, 
salaries will increase at a lesser rate than store sales. 

   Amortization of goodwill and other intangibles in 1997 and 1996 was $5.3 
million and $16.2 million, respectively. The decrease in amortization is 
principally a result of the completion in 1996 of amortization of covenants 
not to compete and the related write-off of the balance of such amounts 
during the fourth quarter of 1996. 

                               12           
<PAGE>
   Depreciation was $3.5 million and $3.0 million in 1997 and 1996, 
respectively. 

   Store pre-opening expenses increased to $0.8 million in 1997 from $0.1 in 
1996 due to the opening of seven new store locations in 1997 compared to one 
in 1996. 

   Net interest expense was $34.5 million in 1997 compared to $32.4 million 
in 1996. The increase in interest expense was principally due to (i) higher 
non-cash accretion of the Zero Coupon Notes, (ii) interest related to 
financing of third party accounts receivable and (iii) increased interest on 
borrowings under the revolving credit facility, partially offset by (a) 
reduced interest on term loan borrowings caused by the decrease in average 
balance from $72.0 million for 1996 to $67.4 million for 1997 and a decrease 
in the average interest rate from 9.1% to 8.7% and (b) reduced interest on 
capital lease obligations. 

   The net loss for the Company decreased by $3.2 million from $17.9 million 
in 1996 to $14.7 million in 1997 primarily as a result of an increase in 
sales and gross profit margin and a reduction in amortization expense, 
partially offset by nonrecurring charges (see Note 12 of Notes to 
Consolidated Financial Statements). The Company's EBITDA improved by $7.8 
million or 22.0% to $43.1 million in 1997 compared to $35.3 million in 1996. 
EBITDA as a percentage of sales increased to 10.0% in 1997 from 9.3% in 1996. 

 FISCAL 1996 COMPARED TO FISCAL 1995 

   Net sales in 1996 were $381.5 million, an increase of 13.2% over 1995 net 
sales of $336.9 million. The increase was due to increased comparable store 
sales of 8.3% and the inclusion of eight stores opened during 1995 for the 
entire 1996 period and of one store opened in 1996. The increase in 
comparable store sales was primarily attributable to increased pharmacy 
sales, which increased to 21.8% of total sales in 1996 compared to 19.0% of 
total sales in 1995. 

   Cost of sales as a percentage of net sales decreased to 75.6% for 1996 
from 77.1% for 1995, resulting in an increase in gross profit margin to 24.4% 
for 1996 from 22.9% for 1995. The increase in gross margin resulted from a 
number of factors including (i) lower inventory shrink losses, (ii) increased 
contribution from the sale of generic drugs and private label products, (iii) 
less promotional activity and (iv) lower rent-to-sales ratios in stores 
opened during 1995 and 1994. The increases were partially offset by lower 
gross margins resulting from sales to customers covered by Third Party Plans. 

   Selling, general and administrative expenses were $59.0 million or 15.5% 
of net sales and $50.3 million or 14.9% of net sales in 1996 and 1995, 
respectively. The percentage increase in 1996 compared to 1995 resulted 
principally from higher administrative expenses, including (i) operating 
costs related to the Company's management information systems department, 
(ii) administrative salaries and one time executive search and severance 
expenses and (iii) professional and consulting fees principally for the 
warehouse and loss prevention areas. The increases were partially offset by 
lower store operating expenses as a percentage of net sales primarily due to 
a higher volume of pharmacy sales, which allows the Company to leverage other 
fixed store operating expenses. 

   Amortization of goodwill and other intangibles in 1995 and 1996 was $11.6 
million and $16.2 million, respectively. The increase in amortization was 
caused by an increase in the amortization of covenants not to compete from 
$8.1 million in 1995 to $11.4 million in 1996 and amortization of systems 
installation and integration costs in an amount of $1.4 million in 1996. The 
increase in amortization of covenants not to compete was caused by the 
write-off of the balance of such intangibles in 1996 resulting from the 
termination of the related agreements. Amortization of systems installation 
and integration costs began in 1996. 

   The increase in depreciation from $1.9 million in 1995 to $3.0 million in 
1996 resulted principally from (i) depreciation of data processing equipment 
which began in 1996 and (ii) a full year's depreciation in 1996 of assets of 
eight stores that were opened in 1995. 

   Store pre-opening expenses decreased from $1.1 million in 1995 to $0.1 
million in 1996 due to the opening of one new store in 1996 compared to eight 
in 1995. 

                               13           
<PAGE>
   Net interest expense increased 7.2% to $32.4 million in 1996 from $30.2 
million in 1995. The increase in interest expense was principally due to the 
higher non-cash accretion of the Zero Coupon Notes offset, in part, by 
reduced interest on term loan borrowings resulting from the decrease in 
average outstanding balance from $75.1 million to $72.0 million and a 
decrease in the average interest rate from 9.5% to 9.1%. 

   The net loss for the Company decreased by $0.2 million or 1.1% from $18.1 
million in 1995 to $17.9 million in 1996 primarily as a result of increased 
sales and gross profit margin offset, in part, by increases in selling, 
general and administrative expenses and amortization of intangibles. The 
Company's EBITDA increased by $7.9 million or 28.6% to $35.3 million in 1996 
compared to $27.4 million in 1995. EBITDA as a percentage of sales increased 
to 9.3% in 1996 from 8.2% in 1995. 

LIQUIDITY AND CAPITAL RESOURCES 

   On September 30, 1997, the Company entered into the Old Credit Agreement, 
which provideD for, among other things, $65.5 million of term loans and up to 
$30.0 million of revolving loans. As of December 27, 1997, outstanding 
balances thereunder totaled $89.8 million. The Company utilizes cash flow 
from operations, together with borrowings under the revolving portion of the 
Old Credit Agreement, to fund working capital needs, investing activities 
(consisting primarily of capital expenditures) and financing activities 
(normal debt service requirements, interest payments and repayment of term 
and revolving loans outstanding). 

   In February 1998, the Company successfully completed an initial public 
offering of its stock which was part of a plan to refinance all of the 
Company's existing indebtedness (the "Refinancing Plan") in order to enhance 
the Company's financial flexibility to pursue growth opportunities and 
implement capital improvements. The Refinancing Plan resulted in a reduction 
in the Company's overall indebtedness, a simplification of the Company's 
capital structure and access to additional borrowings. The principal 
components of the Refinancing Plan were; (i) the sale by the Company of 6.7 
million shares of common stock for net proceeds of approximately $102 
million; (ii) the execution of a new secured credit agreement (the "Existing 
Credit Agreement") which provides for borrowings up to approximately $160 
million ($130 million of term loans and up to $30 million of revolving 
loans); (iii) the issuance of $80 million aggregate principal amount of the 
Company's 9-1/4% Senior Subordinated Notes due 2008 (the "Senior Notes") for 
net proceeds of approximately $77 million; (iv) the repayment of all 
outstanding borrowings under the Old Credit Agreement, the outstanding 
principal amount of which was $89.8 million as of December 27, 1997; (v) the 
redemption of the Company's outstanding Zero Coupon Notes; (vi) the 
redemption of the Company's outstanding 12% Senior Notes due 2002; and the 
(vii) Merger of Daboco with and into the Company. The Company believes the 
Refinancing Plan will result in a reduction in overall interest expense 
because total interest expense associated with the Existing Credit Agreement 
and the Senior Notes will be less than the total interest expense associated 
with the 12% Senior Notes due 2002 and the Zero Coupon Notes. The interest 
rates under the Existing Credit Agreement will be approximately the same as 
interest rates under the Old Credit Agreement. 

   Working capital was $37.5 million and $9.9 million as of December 27, 1997 
and December 28, 1996, respectively The increase is primarily due to the 
Company's investing in forward-buy inventory and increases in inventory 
related to the opening of additional stores in the first quarter or 1998. The 
Company's capital requirements primarily result from opening and stocking new 
stores and from the continuing development of new MIS. The Company's ability 
to open stores in 1996 was limited to a certain degree by liquidity 
considerations. The Company believes that there are significant opportunities 
to open additional stores, and currently plans to open 30 to 40 stores in the 
next two years. The Company expects to spend approximately $16 million in 
1998 on capital expenditures primarily for new and replacement stores. 
Working capital is also required to support inventory for the Company's 
existing stores. Historically, the Company has been able to lease its store 
locations The Company has experienced a significant increase in accounts 
receivable due to increased pharmacy sales in connection with Third Party 
Plans, as compared to non-Third Party Plan sales which are generally paid by 
cash or credit card. However, the Company believes that it has adequately 
provided for liquidity by entering into a non-recourse factoring arrangement 
whereby the Company resells accounts receivable associated with Third Party 
Plans. 

                               14           
<PAGE>
   For the fiscal year ended December 28, 1996, net cash provided by 
operating activities was $12.6 million, compared to $6.7 million for the 
fiscal year ended December 30, 1995. The primary reasons for this increase 
relate to an increase in operating earnings before the amortization of 
goodwill and other intangibles, depreciation and amortization of property and 
equipment and interest expenses, partially offset by a decrease in working 
capital primarily due to a decrease in accounts payable. For the fiscal year 
ended December 28, 1996, net cash used in investing activities was $3.8 
million, compared to $12.8 million for the fiscal year ended December 
30,1995. This reduction primarily resulted form a decrease in capital 
expenditures and decreases in systems development costs. For the fiscal year 
ended December 28, 1996, net cash used in financing activities was $10.7 
million, compared to $4.8 million provided by financing activities for the 
fiscal year ended December 30, 1995. This reduction primarily resulted from 
decreased borrowings under the Company's then existing credit facility and a 
decrease in capital lease financing. 

   For the fiscal year ended December 27, 1997, net cash used in operating 
activities was $3.8 million, compared to $12.6 million provided by operating 
activities during the fiscal year ended December 28, 1996. The primary 
reasons for this decrease are (i) an increase in inventory and (ii) an 
increase in accounts receivable due to increased pharmacy sales in connection 
with Third Party Plans. The Company's significant increase in inventory 
resulted from management's decision to take advantage of a number of forward 
purchasing opportunities, accumulate inventory in advance of additional store 
openings and seasonal inventory buildup during 1997. The Company believes 
that the activities did not and will not materially adversely affect its 
liquidity. For the fiscal year ended December 27, 1997, net cash used in 
investing activities was $12.4 million, compared to $3.8 million for the 
fiscal year ended December 28, 1996. This increase primarily resulted from an 
increase in capital expenditures during 1997 partially offset by a decrease 
in systems development costs. For the fiscal year ended December 27, 1997, 
net cash provided by financing activities was $16.2 million, compared to 
$10.7 million used in financing activities for the fiscal year ended December 
28, 1996. This increase primarily resulted from borrowings under the Old 
Credit Agreement which provided for a term loan of $65.5 million and 
borrowings of $24.5 million on a revolving credit facility of $30 million. 
These proceeds were used to repay the outstanding term loan balance of $69.5 
million and the revolving loan balance of $2.5 million. 

   Leases for seven of the Company's stores that generated approximately 
10.7% of the Company's net sales for the fiscal year ended December 27, 1997 
are scheduled to expire before the end of the year 2000. The Company believes 
that it will be able to renew such leases on economically favorable terms or, 
alternatively, find other economically attractive locations to lease. 

   As of December 27, 1997, approximately 1,800 of the Company's 
approximately 2,000 employees were represented by various labor unions and 
were covered by collective bargaining agreements. Pursuant to the terms of 
such collectively bargaining agreements, the Company is required to pay 
certain annual increases in salary and benefits to such employees. The 
Company does not believe that such increases will have a material impact on 
the Company's liquidity or results of operations. 

   Following the implementation of the Refinancing Plan, the Company believes 
that, based on current levels of operations and anticipated growth, cash flow 
from operations, together with other available sources of funds, including 
borrowings under the Existing Credit Agreement, will be adequate for at least 
the next two years to make required payments of principal and interest on the 
Company's indebtedness, to fund anticipated capital expenditures and working 
capital requirements and to comply with the terms of its debt agreements. The 
ability of the Company to meet its debt service obligations and reduce its 
total debt will be dependent upon the future performance of the Company and 
its subsidiaries which, in turn, will be subject to general economic, 
financial, business, competitive, legislative, regulatory and other 
conditions, many of which are beyond the Company's control. In addition, 
there can be no assurance that the Company's operating results, cash flow and 
capital resources will be sufficient for repayment of its indebtedness in the 
future. Substantially all of the Company's borrowings under the Existing 
Credit Agreement bear interest at floating rates; therefore, the Company's 
financial condition will be affected by the changes in prevailing interest 
rates. The Company expects to enter into interest rate protection agreements 
to minimize the impact from a rise in interest rates. 

TAX BENEFITS FROM NET OPERATING LOSSES 

   At December 27, 1997, the Company had net operating loss carryforwards 
("NOLs") of approximately $71.0 million, which are due to expire in the years 
2007 through 2012. These NOLs may be used 

                               15           
<PAGE>
to offset future taxable income through 2012 and thereby reduce or eliminate 
the Company's federal income taxes otherwise payable. The Internal Revenue 
Code of 1986, as amended (the "Code"), imposes significant limitations on the 
utilization of NOLs in the event of an "ownership change," as defined in 
Section 382 of the Code (the "Section 382 Limitation"). The Section 382 
Limitation is an annual limitation on the amount of pre-ownership change NOLs 
that a corporation may use to offset its post-ownership change income. The 
Section 382 Limitation is calculated by multiplying the value of a 
corporation's stock immediately before an ownership change by the long-term 
tax-exempt rate (as published by the Internal Revenue Service). Generally, an 
ownership change occurs with respect to a corporation if the aggregate 
increase in the percentage of stock ownership (by value) of that corporation 
by one or more 5% shareholders (including certain groups of shareholders who 
in the aggregate own at least 5% of that corporation's stock) exceeds 50 
percentage points over a three-year testing period. The Recapitalization 
caused the Company to experience an ownership change. As a result, the 
Company currently is subject to an annual Section 382 Limitation of 
approximately $5.0 million on the amount of NOLs generated prior to the 
Recapitalization that the Company may utilize to offset future taxable 
income. In addition, the Company believes that it will generate approximately 
$42.0 million of NOLs in connection with the Refinancing Plan. Such NOLs will 
not be subject to the Section 382 Limitation and may be utilized to offset 
future taxable income. However, there can be no assurance that any NOLs will 
be able to be utilized by the Company to offset future taxable income or that 
such NOLs will not become subject to limitation due to future ownership 
changes. 

YEAR 2000 COMPLIANCE 

   The Company has several computer software systems which will require 
modification or upgrading to accommodate the year 2000 and thereafter. The 
Company believes that all systems can be changed by the end of 1999 and does 
not expect the cost of the changes to be material to the Company's financial 
condition or results of operations. 

SEASONALITY 

   In general, sales of drugstores items such as prescription drugs, OTC 
drugs and health and beauty care products exhibit limited seasonality in the 
aggregate, but do vary by product category. Quarterly results are primarily 
affected by the timing of new store openings and the sale of seasonable 
products. In view of the Company's recent expansion of seasonal 
merchandising, the Company expects slightly greater revenue sensitivity 
relating to seasonality in the future. 

INFLATION 

   The Company believes that inflation has not had a material impact on 
results of operations for the Company during the three years ended December 
27, 1997. 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS 

   In February 1997, the Financial Accounting Standards Board issued SFAS No. 
128, "Earnings per Share," which requires the presentation of basic and 
diluted earnings per share in a company's financial statements for reporting 
periods ending subsequent to December 15, 1997. As of December 27, 1997, 
there were outstanding options to purchase an aggregate of 1.65 million 
shares of Common Stock, which shares are not included in the calculation of 
earnings per share for the 52 weeks ended December 27, 1997 and would not be 
included in such calculation under the guidance prescribed by SFAS No. 128 
because of the anti-dilutive nature of these instruments. 

                               16           
<PAGE>
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. 

                               17           
<PAGE>
                      REPORT OF INDEPENDENT ACCOUNTANTS 

To the Board of Directors and 
Stockholders of Duane Reade Inc. 

   In our opinion, the accompanying consolidated balance sheets and the 
related consolidated statements of operations, stockholders' 
equity/(deficiency) and cash flows present fairly, in all material respects, 
the financial position of Duane Reade Inc. (formerly known as Duane Reade 
Holding Corp.) and its subsidiaries at December 27, 1997 and December 28, 
1996 and the results of their operations and their cash flows for each of the 
52 week periods ended December 27, 1997, December 28, 1996 and December 30, 
1995 in conformity with generally accepted accounting principles. These 
financial statements are the responsibility of the Company's management; our 
responsibility is to express an opinion on these financial statements based 
on our audits. We conducted our audits of these statements in accordance with 
generally accepted auditing standards which require that we plan and perform 
the audit to obtain reasonable assurance about whether the financial 
statements are free of material misstatement. An audit includes examining, on 
a test basis, evidence supporting the amounts and disclosures in the 
financial statements, assessing the accounting principles used and 
significant estimates made by management and evaluating the overall financial 
statement presentation. We believe that our audits provide a reasonable basis 
for the opinion expressed above. 

Price Waterhouse LLP 
New York, New York 
March 6, 1998 

                               18           
<PAGE>
                               DUANE READE INC. 
                    Consolidated Statements of Operations 
                   (In thousands, except per share amounts) 

<TABLE>
<CAPTION>
                                                         FOR THE 52 WEEKS ENDED 
                                             ---------------------------------------------- 
                                              DECEMBER 27,    DECEMBER 28,   DECEMBER 30, 
                                                  1997            1996           1995 
                                             -------------- --------------  -------------- 
<S>                                          <C>            <C>             <C>
Net sales ..................................    $429,816        $381,466       $336,922 
Cost of sales ..............................     322,340         288,505        259,827 
                                             -------------- --------------  -------------- 
Gross profit ...............................     107,476          92,961         77,095 
                                             -------------- --------------  -------------- 
Selling, general & administrative expenses        65,414          59,048         50,326 
Amortization ...............................       5,303          16,217         11,579 
Depreciation ...............................       3,507           3,015          1,929 
Store pre-opening expenses .................         767             139          1,095 
Nonrecurring charges .......................      12,726              --             -- 
                                             -------------- --------------  -------------- 
                                                  87,717          78,419         64,929 
                                             -------------- --------------  -------------- 
Operating income ...........................      19,759          14,542         12,166 
Interest expense, net ......................      34,473          32,396         30,224 
                                             -------------- --------------  -------------- 
Loss before income taxes ...................     (14,714)        (17,854)       (18,058) 
Income taxes ...............................          --              --             -- 
                                             -------------- --------------  -------------- 
 Net loss ..................................    $(14,714)       $(17,854)      $(18,058) 
                                             ============== ==============  ============== 
Net loss per common share: 
 Basic .....................................    $  (1.45)       $  (1.77)      $  (1.77) 
                                             ============== ==============  ============== 
 Diluted ...................................    $  (1.45)       $  (1.77)      $  (1.77) 
                                             ============== ==============  ============== 
Weighted average common shares outstanding: 
 Basic .....................................      10,161          10,103         10,178 
                                             ============== ==============  ============== 
 Diluted ...................................      10,161          10,103         10,178 
                                             ============== ==============  ============== 
</TABLE>

  The accompanying notes are an integral part of these financial statements. 

                               19           
<PAGE>
                               DUANE READE INC. 
                         Consolidated Balance Sheets 
                     (In thousands, except share amounts) 

<TABLE>
<CAPTION>
                                                               DECEMBER 27,    DECEMBER 28, 
                                                                   1997            1996 
                                                              -------------- -------------- 
<S>                                                           <C>            <C>
ASSETS 
Current assets 
 Cash........................................................    $    261        $    216 
 Receivables.................................................       9,592           7,171 
 Inventories.................................................      66,665          47,914 
 Prepaid expenses............................................       2,556           1,165 
                                                              -------------- -------------- 
  TOTAL CURRENT ASSETS.......................................      79,074          56,466 
Property and equipment, net..................................      32,557          23,065 
Goodwill, net of accumulated amortization $18,264 and 
$14,785......................................................     120,890         124,369 
Other assets.................................................      17,000          18,576 
                                                              -------------- -------------- 
  TOTAL ASSETS...............................................    $249,521        $222,476 
                                                              ============== ============== 
LIABILITIES AND STOCKHOLDERS' DEFICIENCY 
Current liabilities 
 Accounts payable............................................    $ 23,510        $ 20,015 
 Accrued interest............................................       4,634           3,873 
 Other accrued expenses......................................      10,873           8,157 
 Current portion of long-term debt...........................         660          12,000 
 Current portion of capital lease obligations................       1,903           2,504 
                                                              -------------- -------------- 
  TOTAL CURRENT LIABILITIES..................................      41,580          46,549 
Senior debt, less current portion............................     179,043         149,975 
Subordinated zero coupon debt, net of unamortized discount 
of  $30,827 and $43,899......................................      92,553          79,481 
Capital lease obligations, less current portion..............       3,926           1,697 
Other non-current liabilities................................       6,528           4,170 
                                                              -------------- -------------- 
  TOTAL LIABILITIES..........................................     323,630         281,872 
                                                              -------------- -------------- 
COMMITMENTS AND CONTINGENCIES (NOTE 8) 
Stockholders' deficiency 
 Common stock, $0.01 par; authorized 30,000,000 shares; 
  issued and outstanding 10,260,577 and 10,062,497 shares ...         103             101 
Paid-in capital..............................................      24,563          24,564 
Accumulated deficit .........................................     (98,775)        (84,061) 
                                                              -------------- -------------- 
  TOTAL STOCKHOLDERS' DEFICIENCY.............................     (74,109)        (59,396) 
                                                              -------------- -------------- 
  TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY ............    $249,521        $222,476 
                                                              ============== ============== 
</TABLE>

  The accompanying notes are an integral part of these financial statements. 

                               20           
<PAGE>
                               DUANE READE INC. 
         Consolidated Statements of Stockholders' Equity (Deficiency) 
                     (In thousands, except share amounts) 

<TABLE>
<CAPTION>
                                          COMMON STOCK       
                                     ----------------------  PAID-IN    ACCUMULATED 
                                        SHARES      AMOUNT   CAPITAL      DEFICIT       TOTAL 
                                     ------------ -------- ---------- ------------  ------------
<S>                                  <C>          <C>       <C>       <C>            <C>
Balance, December 31, 1994 .........  10,164,214     $102    $24,877     $(48,149)     $(23,170) 
Sale of common stock to executives        40,692       --        100           --           100 
Repurchase of common stock .........     (20,341)      --        (68)          --           (68) 
Net loss ...........................          --       --         --      (18,058)      (18,058) 
                                     ------------ --------  --------- -------------  ----------- 
Balance, December 30, 1995 .........  10,184,565      102     24,909      (66,207)      (41,196) 
Repurchase of common stock .........    (122,068)      (1)      (345)          --          (346) 
Net loss ...........................          --       --         --      (17,854)      (17,854) 
                                     ------------ --------  --------- -------------  ----------- 
Balance, December 28, 1996 .........  10,062,497      101     24,564      (84,061)      (59,396) 
Issuance of common stock ...........     198,080        2         (1)          --             1 
Net loss ...........................          --       --         --      (14,714)      (14,714) 
                                     ------------ --------  --------- -------------  ----------- 
Balance, December 27, 1997 .........  10,260,577     $103    $24,563     $(98,775)     $(74,109) 
                                     ============ ========  ========= =============  =========== 
</TABLE>

  The accompanying notes are an integral part of these financial statements. 

                               21           
<PAGE>
                               DUANE READE INC. 
                    Consolidated Statements of Cash Flows 
                                (In thousands) 

<TABLE>
<CAPTION>
                                                                 FOR THE 52 WEEKS ENDED 
                                                     ---------------------------------------------- 
                                                      DECEMBER 27,    DECEMBER 28,   DECEMBER 30, 
                                                          1997            1996           1995 
                                                     -------------- --------------  -------------- 
<S>                                                  <C>            <C>             <C>
Cash flows from operating activities: 
 Net loss...........................................    $(14,714)       $(17,854)      $(18,058) 
 Adjustments to reconcile net loss to net cash 
  provided by operating activities: 
  Depreciation and amortization of property and 
   equipment........................................       3,507           3,015          1,929 
  Amortization of goodwill and other intangibles ...       9,542          18,897         13,940 
  Accretion of principal of zero coupon debt .......      13,081          11,249          9,628 
  Other.............................................       1,761           1,526          1,769 
Changes in operating assets and liabilities: 
 Receivables........................................      (2,421)         (1,431)        (1,962) 
 Inventories........................................     (18,751)         (4,767)        (6,745) 
 Accounts payable...................................       3,495            (412)         7,382 
 Prepaid and accrued expenses.......................       2,086           2,321           (658) 
Increase in other (liabilities) assets--net ........      (1,392)             51           (491) 
                                                     -------------- --------------  -------------- 
 NET CASH (USED IN) PROVIDED BY OPERATING 
  ACTIVITIES .......................................      (3,806)         12,595          6,734 
                                                     -------------- --------------  -------------- 
Cash flows from investing activities: 
 Proceeds from sales of capital assets..............       1,075              --             -- 
 Capital expenditures...............................     (13,493)         (1,247)        (6,868) 
 Systems development costs..........................          --          (2,566)        (6,268) 
 Sale of government securities--net.................          --              44            382 
                                                     -------------- --------------  -------------- 
 NET CASH USED IN INVESTING ACTIVITIES..............     (12,418)         (3,769)       (12,754) 
                                                     -------------- --------------  -------------- 
Cash flows from financing activities: 
 Proceeds from new term loan........................      65,475              --             -- 
 Borrowings from new revolving credit facility .....      24,500              --             -- 
 Repayments of old term loan........................     (69,475)         (5,625)       (15,000) 
 Net borrowings (repayments)--old revolving credit 
  facility..........................................      (2,500)         (1,500)         4,000 
 Repayments of other long-term borrowings ..........        (116)             --             -- 
 Financing costs....................................      (3,079)           (952)          (885) 
 Repayments of new term loan........................        (165)             --             -- 
 Proceeds from issuance of long-term debt ..........          --              --         15,000 
 Proceeds from issuance of stock....................           1              --             25 
 Repurchase of stock................................          --             (95)           (68) 
 Capital lease financing............................       4,133             274          4,329 
 Repayments of capital lease obligations............      (2,505)         (2,845)        (2,617) 
                                                     -------------- --------------  -------------- 
 NET CASH PROVIDED BY (USED IN) FINANCING 
  ACTIVITIES .......................................      16,269         (10,743)         4,784 
                                                     -------------- --------------  -------------- 
Net increase (decrease) in cash ....................          45          (1,917)        (1,236) 
Cash at beginning of year ..........................         216           2,133          3,369 
                                                     -------------- --------------  -------------- 
CASH AT END OF YEAR ................................    $    261        $    216       $  2,133 
                                                     ============== ==============  ============== 
Supplementary disclosures of cash flow information: 
Cash paid for interest .............................    $ 17,601        $ 18,391       $ 18,298 
                                                     ============== ==============  ============== 
</TABLE>

  The accompanying notes are an integral part of these financial statements. 

                               22           
<PAGE>
                               DUANE READE INC. 
                       NOTES TO CONSOLIDATED STATEMENTS 

1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

   Duane Reade Inc. (the "Company") was formed on June 16, 1992 for the 
purpose of acquiring Daboco, Inc. ("Daboco"). The acquisition took place on 
September 25, 1992. Daboco and Duane Reade Inc. ("DR Inc."), a subsidiary of 
Daboco, are general partners in Duane Reade, which operates a chain of retail 
drug stores (67 at December 27, 1997) in the New York City area. 

   Also in June 1997, the Company entered into a recapitalization (Note 10). 

   Significant accounting policies followed in the preparation of the 
consolidated financial statements are as follows: 

   PRINCIPLES OF CONSOLIDATION: The consolidated financial statements include 
the accounts the Company and its subsidiaries. All intercompany transactions 
and balances have been eliminated. Certain prior period amounts have been 
reclassified to conform with the current presentation. 

   REPORTING YEAR: The fiscal year for the Company is the 52/53 week 
reporting period ending on the last Saturday in December. 

   RECEIVABLES: Receivables consist primarily of amounts due from various 
insurance companies and governmental agencies under third party payment plans 
for prescription sales and amounts due from vendors, a majority of which 
relate to promotional programs. The Company has not provided an allowance for 
doubtful accounts as its historical write-offs have been immaterial. The 
Company reflects promotional allowances from vendors as income when such 
allowances are earned. The carrying value of the Company's receivables 
approximate fair value given the short-term maturity of these financial 
instruments. 

   INVENTORIES AND COST OF SALES: Substantially all inventories are stated at 
the lower of cost, determined pursuant to the last-in, first-out retail 
dollar value method (LIFO), or market. When appropriate, provision is made 
for obsolete, slow-moving or damaged inventory. If current cost had been 
used, inventories at December 27, 1997 and December 28, 1996 would not be 
materially different from the amounts reflected on the accompanying balance 
sheets. Cost of sales includes distribution and occupancy costs. 

   PROPERTY AND EQUIPMENT: Property and equipment are stated at cost. 
Depreciation and amortization are provided using the straight-line method 
over estimated useful lives of assets as follows: 

<TABLE>
<CAPTION>
<S>                                     <C>
 Buildings and improvements ............30 years 
Furniture, fixtures and equipment  .... 5-10 years 
Leasehold improvements ................ Life of lease or, if shorter, asset 
Property under capital leases ......... 7 years 
</TABLE>

   OTHER ASSETS: Deferred financing costs arose in connection with borrowings 
under the Term Loan and with the issuance of the Senior Subordinated Notes 
and the Zero Coupon Notes and are amortized using the straight-line method, 
the results of which are not materially different from the interest method, 
over the term of the respective debt issue. Deferred financing costs which 
arose in connection with the September 30, 1997 credit agreement are 
amortized utilizing the interest method, over the term of the debt. Deferred 
financing costs which arose in connection with the Old Credit Agreement are 
amortized utilizing the interest method over the term of the debt. 

   Systems development costs, consisting principally of costs relating to the 
new management information systems, are amortized using the straight-line 
method commencing in 1996 over a period of seven years. 

   INTANGIBLE ASSETS: In September 1992, Holdings and Duane Reade entered 
into agreements with certain former members of management of Duane Reade, 
former shareholders of Daboco and 

                               23           
<PAGE>
shareholders of former partners of Duane Reade (collectively, the "Group") 
precluding such persons from competing with the operations of Duane Reade for 
a period of five years. The covenants not to compete were recorded at 
acquisition cost and were being amortized over the period of benefit using an 
accelerated method. During the first quarter of 1997, Holdings and Duane 
Reade entered into agreements in which the Company received consideration 
from the Group to terminate the non-compete agreements. In accordance with 
APB Opinion No. 17, Intangible Assets, the remaining carrying value of the 
non-compete agreements of $4.86 million as of December 28, 1996 was written 
off and has been included in the accompanying consolidated statement of 
operations as amortization expense. 

   Goodwill is amortized on the straight-line method over 40 years. The 
carrying value of goodwill is periodically reviewed and evaluated by the 
Company based principally on its expected future undiscounted operating cash 
flows. Should such evaluation result in the Company concluding that the 
carrying amount of goodwill has been impaired, an appropriate write-down 
would be made. 

   PRE-OPENING EXPENSES: Store pre-opening costs, other than capital 
expenditures, are expensed when incurred. 

   INCOME TAXES: Income taxes are accounted for under the liability method 
prescribed by Statement of Financial Accounting Standards No. 109. 

   RECENTLY ISSUED ACCOUNTING STANDARDS: The Financial Accounting Standards 
Board (FASB) has issued several accounting pronouncements which the company 
will be required to adopt in future periods. 

   FASB Statement No. 130 "Reporting Comprehensive Income," which the Company 
will adopt during the first quarter of 1998, establishes standards for 
reporting and display of comprehensive income and its components in financial 
statements. Comprehensive income generally represents all changes in 
shareholders' equity except those resulting from investments by or 
distributions to shareholders. With the exception of net earnings, such 
changes are generally not significant to the Company and the adoption of 
Statement No. 130, including the required comparative presentation for prior 
periods, is not expected to have a material impact on the consolidated 
financial statements. 

   FASB Statement No. 131 "Disclosures about Segments of an Enterprise and 
Related Information" requires that a publicly-held company report financial 
and descriptive information about its operating segments in the consolidated 
financial statements issued to shareholders for interim and annual periods. 
In addition, the Statement also requires additional disclosures with respect 
to products and services, geographic areas of operation, and major customers 
which have not previously been presented in the consolidated financial 
statements and related notes. The Company will adopt Statement No. 131 in 
1998. 

   ACCOUNTING ESTIMATES: The preparation of financial statements in 
conformity with generally accepted accounting principles requires management 
to make estimates and assumptions that affect the reported amounts of assets 
and liabilities and disclosures of contingent assets and liabilities at the 
date of the financial statements and the reported amounts of revenues, costs 
and expenses during the reporting period. Actual results could differ from 
those estimates. 

   NET LOSS PER COMMON SHARE: Net loss per common share is based on the 
weighted average shares outstanding during each period (10,160,851 for the 52 
weeks ended December 27, 1997; 10,103,186 for the 52 weeks ended December 28, 
1996 and 10,177,782 for the 52 weeks ended December 30, 1995). The Company 
adopted the provisions of FASB Statement No. 128 "Earnings per Share" in 
1997. Basic earnings per share is computed based on the weighted average 
number of common shares outstanding during the period. Diluted earnings per 
share gives effect to all dilutive potential common shares outstanding during 
the period. Potential common shares include shares issuable upon exercise of 
the Company's stock options. 

   Potential common shares relating to options to purchase common stock were 
not included in the weighted average number of shares for the fiscal years 
1997, 1996 and 1995 because their effect would have been anti-dilutive. 

                               24           
<PAGE>
2. PROPERTY AND EQUIPMENT 

   Property and equipment are summarized as follows (in thousands): 

<TABLE>
<CAPTION>
                                                  DECEMBER 27,    DECEMBER 28, 
                                                      1997            1996 
                                                 -------------- -------------- 
<S>                                              <C>            <C>
Land............................................     $   312        $   489 
Buildings and building improvements ............       4,323          4,523 
Furniture, fixtures and equipment ..............      11,367          6,881 
Leasehold improvements .........................      17,620         13,134 
Property under capital leases ..................       9,410          5,063 
                                                 -------------- -------------- 
                                                      43,032         30,090 
Less--Accumulated depreciation and amortization.      10,475          7,025 
                                                 -------------- -------------- 
                                                     $32,557        $23,065 
                                                 ============== ============== 
</TABLE>

3. OTHER ASSETS 

   Other assets are summarized as follows (in thousands): 

<TABLE>
<CAPTION>
                                                    DECEMBER 27,    DECEMBER 28, 
                                                        1997            1996 
                                                   -------------- -------------- 
<S>                                                <C>            <C>
Deferred financing costs (net of accumulated 
 amortization of $4,117 and $10,417) .............     $ 6,651        $ 7,811 
Systems and integration costs (net of accumulated 
 amortization of $3,009 and $1,461) ..............       8,231          9,798 
Other ............................................       2,118            967 
                                                   -------------- -------------- 
                                                       $17,000        $18,576 
                                                   ============== ============== 
</TABLE>

   Included in other assets are notes receivable from executives in the 
amount of $237,000 at December 27, 1997 and $381,000 at December 28, 1996. 

4. DEBT 

   Long-term debt consists of the following (in thousands): 

<TABLE>
<CAPTION>
                                               DECEMBER 27,    DECEMBER 28, 
                                                   1997            1996 
                                              -------------- -------------- 
<S>                                           <C>            <C>
Senior debt 
 Term loan facility (A) .....................    $ 65,310        $ 69,475 
 Notes payable bank--revolving credit (A)  ..      24,500           2,500 
 12% Senior Notes due September 15, 2002 (B)       89,893          90,000 
Subordinated debt 
 15% Senior Subordinated Zero Coupon Notes 
  due September 15, 2004 (C) ................      92,553          79,481 
                                              -------------- -------------- 
                                                  272,256         241,456 
 Less--Current portion ......................         660          12,000 
                                              -------------- -------------- 
                                                 $271,596        $229,456 
                                              ============== ============== 
</TABLE>

   Amounts presented above are classified based upon their scheduled maturity 
dates. As noted below, all amounts were repaid during the first quarter of 
1998 in connection with the Company's Existing Credit Agreement and the 
issuance of common stock and Senior Notes. 

   (A) Outstanding balances under a credit agreement dated as of September 
       24, 1992, as amended, with a syndicate of lending institutions bear 
       interest at floating rates, which at December 27, 

                               25           
<PAGE>
       1997 averaged 8.9%. On September 30, 1997, the Company entered into a 
       credit agreement (the "Old Credit Agreement") with an affiliate of the 
       DLJMB Entities and various financial institutions providing for a term 
       loan of $65.5 million and a revolving credit facility of $30 million. 
       Proceeds of the term loan were used to repay outstanding term loans 
       ($63.5 million) and revolving loans ($2 million). 

       The term loan is payable in quarterly installments of $165,000 from 
       December 1997 through March 2001, with additional payments as outlined 
       in schedule below. The balance of the term loan at December 27, 1997 
       of $65.3 million reflects the above amount less the first quarterly 
       payment made in December. As of December 27, 1997, the borrowings 
       outstanding under the revolving credit facility were $24.5 million 
       (classified as a noncurrent liability); in addition, $285,000 in 
       letters of credit had been issued. 

       At December 27, 1997, the aggregate principal amount of the term loan 
       matures as follows (in thousands): 

<TABLE>
<CAPTION>
<S>                <C>
1998.............  $   660 
1999.............      660 
2000.............      660 
2001.............   31,495 
2002.............   31,835 
                 --------- 
                   $65,310 
                 ========= 
</TABLE>

       Subject to certain conditions, voluntary prepayments of the Term Loan 
       are permitted without premium or penalty. Mandatory prepayments are 
       required with respect to asset sales, permitted issuance of debt or 
       equity and 75% of excess cash flows, as defined in the Credit 
       Agreement, as amended. 

       Obligations under the Old Credit Agreement are secured by a pledge of 
       all of Duane Reade's tangible and intangible assets and are guaranteed 
       by the Company which has pledged 100% of its partnership interests in 
       support of such guarantees. The guarantees are joint and several and 
       full and unconditional. The Old Credit Agreement contains restrictions 
       on indebtedness, asset sales, dividends and other distributions, 
       capital expenditures, transactions with affiliates and other unrelated 
       business activities. Financial performance covenants include interest 
       coverage, leverage ratio, minimum net worth and fixed charge coverage. 
       At December 27, 1997, the Company is in compliance with all of the 
       covenants in the Old Credit Agreement. 

   (B) On September 25, 1992, Duane Reade issued $90,000,000 aggregate 
       principal amount of 12% Senior Notes due September 15, 2002, at face 
       value. Interest is payable at 12% semiannually. The Senior Notes are 
       guaranteed by Daboco and DR Inc. All of Daboco's assets are pledged to 
       secure indebtedness under the Credit Agreement discussed in (A) above. 
       As a result, such indebtedness will have claim on those assets that is 
       prior to the claim of holders of the Senior Notes. To the extent that 
       the amount of senior indebtedness exceeds the value of the collateral 
       securing such indebtedness, the Senior Notes will rank pari passu with 
       the Term Loans. 

       Duane Reade is required to make a sinking fund payment on September 
       15, 2001 sufficient to retire 50% of the aggregate principal amount of 
       Senior Notes originally issued. The Senior Notes are subject to 
       redemption at the option of the issuer at 104.5% of par, plus accrued 
       interest, at the end of 1997, declining to par, plus accrued interest, 
       at the end of 2000. In the event of a change in control, Duane Reade 
       shall be obligated to make an offer to purchase all outstanding Senior 
       Notes at a repurchase price of 101% of the principal amount. 

   (C) On September 25, 1992, Holdings issued $123,380,000 aggregate 
       principal amount of 15% Senior Subordinated Zero Coupon Notes due 
       September 15, 2004 (the "Zero Coupon Notes"), net of an $81,909,000 
       discount. The discount accretes through the Final Accretion Date of 

                               26           
<PAGE>
       September 15, 1999. Thereafter, cash interest is payable at 15% 
       semi-annually through maturity. Interest expense is determined using 
       the effective interest method, which applies a constant yield to 
       carrying value over the life of the Zero Coupon Notes. 

       The Credit Agreement and the Senior Note Indenture referred to in (A) 
       and (B) above provide for subordination of Holdings' debt to 
       partnership debt. 

       The notes are redeemable at the option of the issuer, in whole or in 
       part, at 107.5% of Accreted Value (as defined in the Zero Coupon Note 
       Indenture), plus accrued interest, at the end of 1997 declining to 
       par, plus accrued interest, at the end of 2002. In the event of a 
       change in control, Holdings shall be obligated to make an offer to 
       purchase all outstanding Zero Coupon Notes at a repurchase price of 
       101% of Accreted Value (as defined in the Indenture) or principal 
       amount, as applicable. The Accreted Value of the Zero Coupon Notes was 
       $96,400,000 at December 27, 1997. 

       Purchasers of the Zero Coupon Notes received 15% of the fully diluted 
       common stock of the Company, with registration rights, for aggregate 
       consideration of $3,529,000. 

       The Indentures governing the Zero Coupon Notes and the Senior Notes 
       include certain restrictive covenants. Subject to certain exceptions, 
       the Indentures restrict transactions with affiliates, the incurrence 
       of additional indebtedness, the payment of dividends, the creation of 
       liens, certain asset sales, mergers and consolidations and certain 
       other payments. 

       The Company's debt is thinly traded in the market place. Accordingly, 
       management is unable to determine fair market values for such debt at 
       December 27, 1997. 

       The Zero Coupon Notes and the Senior Notes were issued pursuant to 
       Registration Rights Agreements under which Holdings and Duane Reade 
       consummated registered exchange offers pursuant to which Holdings and 
       Duane Reade exchanged the Zero Coupon Notes and the Senior Notes, 
       respectively, for identical notes which have been registered under the 
       Securities Act of 1933, as amended. 

   In connection with the Company's new credit agreement (the "Existing 
Credit Agreement") issuance of common stock and Senior Notes in February 
1998, all outstanding amounts under (A), (B) and (C) above were repaid in 
full (see Note 15). 

5. CAPITAL LEASE OBLIGATIONS 

   As of December 27, 1997, the present value of capital lease obligations 
was $5.8 million (of which $1.9 million was payable during the next twelve 
months). Such obligations are payable in monthly installments over three to 
five year periods and bear interest at an average rate of 12.8%. 

                               27           
<PAGE>
6. INCOME TAXES 

   Deferred tax assets and liabilities are determined based on the difference 
between book and tax bases of the respective assets and liabilities at 
December 27, 1997, December 28, 1996 and December 30, 1995 and are comprised 
of (in thousands): 

<TABLE>
<CAPTION>
                                   DECEMBER 27,    DECEMBER 28,   DECEMBER 30, 
                                       1997            1996           1995 
                                  -------------- --------------  -------------- 
<S>                               <C>            <C>             <C>
Inventories......................    $ (3,884)      $  (3,501)     $  (3,238) 
                                  -------------- --------------  -------------- 
Gross deferred tax liabilities ..      (3,884)         (3,501)        (3,238) 
                                  -------------- --------------  -------------- 
Covenants not to compete ........          --           1,851          4,318 
Zero Coupon debt discount  ......      19,838          14,041          9,885 
Other ...........................       4,474           3,558          2,479 
Net operating loss carryforward        32,255          50,072         49,217 
                                  -------------- --------------  -------------- 
Gross deferred tax assets .......      56,567          69,522         65,899 
                                  -------------- --------------  -------------- 
Net deferred tax assets .........      52,683          66,021         62,661 
Valuation allowance .............     (52,683)        (66,021)       (62,661) 
                                  -------------- --------------  -------------- 
                                     $     --        $     --       $     -- 
                                  ============== ==============  ============== 
</TABLE>

   The Company deducted for income tax purposes for the period September 25 
to December 31, 1992 approximately $88 million of payments made to former 
partners of Duane Reade (the "Retirement Payments"). Approximately $22.2 
million of the valuation allowance relates to the Retirement Payments. The 
Retirement Payments and other current tax deductions resulted in an available 
net operating loss of approximately $68.6 million which may be used to offset 
future taxable income of the Company through 2012. Due to the nature of the 
Retirement Payments, future reductions in that portion of the valuation 
allowance related to the Retirement Payments will be credited to goodwill. 
Further, due to the change in ownership arising as a result of the 
recapitalization, certain income tax law provisions apply which limit the 
ability of the Company to utilize the available net operating loss 
carryforwards. It is estimated that the annual limitation will be $5.1 
million. 

   The provision for income taxes for the 52 weeks ended December 27, 1997, 
December 28, 1996 and December 30, 1995 differs from the amounts of income 
tax determined by applying the applicable U.S. statutory federal income tax 
rate to pretax loss as a result of the following (in thousands): 

<TABLE>
<CAPTION>
                                       52 WEEKS ENDED        52 WEEKS ENDED         52 WEEKS ENDED 
                                      DECEMBER 27, 1997     DECEMBER 28, 1996     DECEMBER 30, 1995 
                                    --------------------- --------------------- --------------------- 
<S>                                 <C>         <C>       <C>         <C>       <C>         <C>
Pretax accounting loss.............   $(14,714)   100.0%    $(17,854)   100.0%    $(18,058)   100.0% 
                                    ----------- --------  ----------- --------  ----------- -------- 
Statutory rate ....................     (5,150)   (35.0)      (6,249)   (35.0)      (6,320)   (35.0) 
State and local taxes, net of 
 federal tax ......................       (332)    (2.3)      (1,201)    (6.7)      (1,233)    (6.8) 
Goodwill amortization .............      1,218      8.3        1,218      6.8        1,218      6.7 
Net operating losses not utilized        1,530     10.4        5,534     31.0        5,828     32.3 
Nondeductible interest expense  ...        796      5.4          684      3.8          585      3.2 
Nondeductible recapitalization  ...      1,915     13.0            0      0.0            0      0.0 
Other .............................         23      0.2           14      0.1          (78)    (0.4) 
                                    ----------- --------  ----------- --------  ----------- -------- 
Effective tax rate.................   $     --       --%    $     --       --%    $     --       --% 
                                    =========== ========  =========== ========  =========== ======== 
</TABLE>

7. STORE PRE-OPENING EXPENSES 

   Duane Reade opened seven new store locations during the 52 weeks ended 
December 27, 1997, one new store location during the 52 weeks ended December 
28, 1996 and eight new store locations during the 52 weeks ended December 30, 
1995. 

                               28           
<PAGE>
8. COMMITMENTS AND CONTINGENCIES 

LEASES 

   Duane Reade leases all of its store facilities under operating lease 
agreements expiring on various dates through the year 2022. In addition to 
minimum rentals, certain leases provide for annual increases based upon real 
estate tax increases, maintenance cost increases and inflation. Rent expense 
for the 52 weeks ended December 27, 1997, December 28, 1996 and December 30, 
1995 was $26,587,000, $24,420,000 and $22,703,000, respectively. 

   Minimum annual rentals at December 27, 1997 (including obligations under 
new store leases entered into but not opened as of December 27, 1997) are as 
follows (in thousands): 

<TABLE>
<CAPTION>
                <S>                     <C>
                 1998...................  $ 28,899 
                 1999...................    29,300 
                 2000...................    28,512 
                 2001...................    28,204 
                 2002...................    27,682 
                 Remaining lease terms..   155,071 
                                        ---------- 
                 Total..................  $297,668 
                                        ========== 
</TABLE>

LITIGATION 

   The Company from time to time is involved in routine legal matters 
incidental to its business. In the opinion of management, the ultimate 
resolution of such matters will not have a material adverse effect on the 
Company's financial position, results of operations or liquidity. 

MANAGEMENT AGREEMENTS 

   The Company has employment agreements with several of its executives 
providing, among other things, for employment terms of up to three years. 
Pursuant to the terms of such employment and related agreements, the Company 
and various executives entered into agreements pursuant to which (i) 
executives' salary and bonuses were established and (ii) executives purchased 
shares of common stock. In the event of employment termination, all of the 
stock may be repurchased by the Company. As a result of the recapitalization 
and the reverse stock split (Note 10), all outstanding shares were converted 
into common stock. As of December 27, 1997, an aggregate 287,578 shares of 
common stock are held by employees and former employees. 

COMMITMENTS 

   The Company has established a Supplemental Executive Retirement Plan 
("SERP") which presently covers only its Chairman. Such SERP provides for 
vesting over a twenty year period. However, if the Chairman's employment is 
terminated without cause, as defined, or if the Chairman resigns with cause, 
as defined, such vesting becomes immediate, in which event the Company would 
be liable to the Chairman (in addition to amounts accrued in the financial 
statements) in the amount of approximately $700,000. 

   The Company is subject to a loan agreement between the Company, certain of 
the DLJMB Entities and an Executive of the Company whereby the Company has an 
obligation to assume a $1 million loan made to said executive, should the 
DLJMB Entities elect. At December 27, 1997, the DLJMB Entities have not 
exercised such election. 

9. EMPLOYEE BENEFIT PLANS 

   On October 12, 1992, the Company adopted the 1992 Stock Option Plan of 
Duane Reade Holding Corp. (the "Plan"). Under the Plan, a committee 
designated by the Board of Directors to administer the Plan (the "Committee") 
may grant, to executive and other key employees of the Company, nonqualified 
stock options to purchase up to an aggregate of 510,757 (adjusted for the 
recapitalization--See Note 

                               29           
<PAGE>
10--and the reverse stock split--see Note 15) shares of common stock of the 
Company at an exercise price fixed by the Committee. The options are 
exercisable at such time or times as the Committee determines at or 
subsequent to grant. The term of the options set by the Committee shall not 
exceed 10 years. 

   At December 27, 1997, there were outstanding nonqualified stock options to 
purchase up to an aggregate of 635,207 (adjusted for the recapitalization and 
the reverse stock split-Note 10) shares of common stock (including options 
granted outside the Plan), all of which are vested. 

   Changes in options outstanding (including options granted outside the 
Plan) during 1997 and 1996 are summarized as follows: 

<TABLE>
<CAPTION>
                                                             OPTION PRICE PER SHARE 
                                        ----------------------------------------------------------------- 
                                                                                                TOTAL 
                                            $.58      $7.34-$12.77     $29.37      $40.86      OPTIONS 
                                        ----------- --------------  ----------- -----------  ----------- 
<S>                                     <C>         <C>             <C>         <C>          <C>
Options outstanding, December 30, 
 1995..................................     40,110       40,109        40,109       40,109      160,437 
Options granted .......................    723,662        2,745         2,745        2,745      731,897 
Options canceled ......................    (13,728)     (13,726)      (13,726)     (13,726)     (54,906) 
                                        ----------- --------------  ----------- -----------  ----------- 
Options outstanding, December 28, 
 1996..................................    750,044       29,128        29,128       29,128      837,428 
Options granted .......................        851       68,953           851          851       71,506 
Options exercised .....................     (2,745)          --            --           --       (2,745) 
Options canceled ......................   (262,747)      (2,745)       (2,745)      (2,745)    (270,982) 
                                        ----------- --------------  ----------- -----------  ----------- 
Options outstanding, December 27, 
 1997..................................    485,403       95,336        27,234       27,234      635,207 
                                        =========== ==============  =========== ===========  =========== 
Weighted average remaining life on 
 outstanding options ..................  8.2 years        8.3 years  6.2 years    6.2 years   8.1 years 
</TABLE>

   During the second quarter of 1997, the Company adopted an Equity 
Participation Plan under which options for a total of 1,321,181 (adjusted for 
the recapitalization and the reverse stock split--Note 10) shares of common 
stock of the Company may be granted to employees, consultants and 
non-employee directors of the Company if the Company meets specific 
performance targets. At December 27, 1997, options for 1,019,284 shares have 
been granted to employees. 

   Changes in options outstanding under the Equity Participation Plan during 
the 52 weeks ended December 27, 1997 are summarized as follows: 

<TABLE>
<CAPTION>
                                            NUMBER 
                                          OF OPTIONS    OPTION PRICE 
                                         ------------ -------------- 
<S>                                      <C>          <C>
Options outstanding, December 28, 1996            --          -- 
Options granted ........................   1,019,284       $8.33 
                                         ------------ -------------- 
Options outstanding, December 27, 1997     1,019,284       $8.33 
                                         ============ ============== 
</TABLE>

   As permitted, the Company applies Accounting Principles Board Opinion No. 
25 and related Interpretations in accounting for its stock-based compensation 
plan. Had compensation cost for the Company's stock-based compensation plan 
been determined based on the fair value at the grant dates for awards under 
the Plan, consistent with the alternative method of Statement of Financial 
Accounting Standards No. 123, "Accounting for Stock-Based Compensation," the 
pro forma effect on the Company's net loss for the 52 weeks ended December 
27, 1997 and December 28, 1996 would have been less than $100,000 and 
$200,000, respectively. The pro forma compensation expense for stock options 
has been estimated using the Black-Scholes option pricing model with the 
following assumptions: dividend yield of 0.0%, expected volatility of 60.0%, 
risk free interest rate of 6.0% and an expected term of 8 years. These pro 
forma disclosures may not be representative of the effects of reported income 
for future years since options vest over several years and options granted 
prior to 1995 are not considered. 

   The Company maintains an employee savings plan pursuant to Section 401(k) 
(the "401(k) Plan") of the Internal Revenue Code ("IRC") which covers 
substantially all non-union employees other than key 

                               30           
<PAGE>
employees as defined by IRC. Eligible participating employees may contribute 
up to 10% of their pretax salaries, subject to certain IRC limitations. The 
401(k) Plan, as amended, provides for employer matching provisions at the 
discretion of the Company (to a maximum of 1% of pretax salaries) and has a 
feature under which the Company may contribute additional amounts for all 
eligible employees. The Company's policy is to fund such costs under the 
401(k) Plan as accrued. For the 52 weeks ended December 27, 1997 and December 
28, 1996, there were no employer contributions to the 401(k) Plan. For the 52 
weeks ended December 30, 1995, employer contributions to the 401(k) Plan were 
$166,000. 

   Duane Reade is under contract with local unions to contribute to 
multi-employer pension and welfare benefit plans for certain of its 
employees. For the 52 weeks ended December 27, 1997, December 28, 1996 and 
December 30, 1995, contributions to such plans were $6,751,000, $5,783,000 
and $5,200,000, respectively. 

10. RECAPITALIZATION 

   During June 1997, the Company entered into a recapitalization agreement 
(the "Agreement") with its stockholders ("Stockholders") and certain 
investors ("Investors"). The Agreement provided for (i) the purchase by 
Investors from the Stockholders of substantially all their stock holdings in 
the Company, (ii) a conversion of all of the outstanding shares of the 
Company into a newly authorized class of Class B Common stock and (iii) the 
creation of a new authorized class of preferred stock which will carry the 
rights and preferences granted by the Company's Board of Directors when 
issued. 

   Shares were converted as follows: 

<TABLE>
<CAPTION>
                                                   APPROXIMATE 
                                                    CONVERSION 
           PRIOR CLASS                                 RATE 
           -----------                               -------- 
<S>                                                  <C>
Common and Common Class A ...............               28/1 
Common Class P and Common Class P-1  ....              355/1 
</TABLE>

   In addition, because of the change in control, the Company was obligated 
to and made offers to repurchase all outstanding Senior Notes and Zero Coupon 
Notes at 101% of the principal amount or accreted value thereof, 
respectively. Such offers expired on September 12, 1997. The Company 
repurchased an aggregate of $107,000 principal amount of Senior Notes and 
$9,000 of Zero Coupon Notes pursuant to the offers. 

   These financial statements do not reflect any adjustments as a result of 
the June 1997 change in control. 

   On January 14, 1998, the Company effected an 8.326 reverse stock split of 
its common stock. All references to common stock amounts, shares and per 
share data included herein have been adjusted to give retroactive effect to 
such reverse stock split. 

11. NONRECURRING CHARGES 

   During the first quarter of 1997, the Company considered a public offering 
of its common stock and took certain steps in connection with these plans. 
Such plans were abandoned upon consummation of the transaction discussed in 
Note 10. 

   Costs and expenses incurred in connection with the abandoned public 
offering, the recapitalization and the exchange offers referred to in Note 10 
aggregated approximately $12.7 million, including investment banking fees of 
$7.7 million (including $3.5 million to an affiliate of the Investors and 
$0.6 million to the Stockholders), write-off of unamortized deferred 
financing costs relating to the old credit agreement of $1.8 million, legal 
and accounting fees of $1.6 million, stand-by commitment fees relating to the 
exchange offers of $1.2 million to an affiliate of the Investors, and other 
costs of $0.4 million. The Company has treated these expenses as 
non-recurring because such expenses related to financing activities in 
connection with the Recapitalization and related events, which the Company 
does not expect to repeat. 

                               31           
<PAGE>
12. RELATED PARTY TRANSACTIONS 

   In 1992, the Company and the then principal stockholder of the Company 
(who has subsequently sold most of its shares, Note 10) entered into a 
professional services agreement whereby consulting, advisory, financial and 
other services were provided at the Company's request, for a five year term. 
During the 52 weeks ended December 28, 1996 and December 30, 1995, such fees 
aggregated approximately $1.0 million. 

   In addition, the Investors paid an executive approximately $0.8 million 
for advisory services rendered and a former executive approximately $1.6 
million for the repurchase and cancellation of exercisable stock options. The 
accompanying financial statements do not reflect such payments. 

   Costs incurred in connection with the Old Credit Agreement aggregated 
approximately $2.7 million (including a funding fee of $2.4 million to an 
affiliate of the). 

13. SUBSEQUENT EVENTS 

   On February 13, 1998, the Company issued 6,700,000 shares of common stock 
in an initial public offering for net proceeds of approximately $101.8 
million. In addition to the issuance of common stock, the Company entered 
into the Existing Credit Agreement which provides for borrowings of up to 
approximately $160 million and issued $80 million of Senior Notes. The net 
proceeds of the common stock, the sale of the Senior Notes and borrowings 
under the Existing Credit Agreement, were used for the (i) redemption of all 
of the Zero Coupon Notes for $99.8 million (including a redemption premium of 
$7.0 million), (ii) redemption of all the Senior Notes for $93.9 million 
(including a redemption premium of $4.0 million), (iii) repayment of the 
outstanding term loan indebtedness of $65.3 million, (iv) repayment of 
outstanding revolving indebtedness of $27.5 million and (v) payment of fees 
and expenses in connection with the Company's refinancing plan. 

   The early payment of the Zero Coupon and Senior Notes will result in an 
extraordinary loss of approximately $23.6 million in the first quarter of 
1998. 

                               32           
<PAGE>
14. SELECTED QUARTERLY INFORMATION (UNAUDITED) 
    (In thousands, except per share amounts) 

<TABLE>
<CAPTION>
 QUARTER                       1997        1996         1995 
- -------------------------  ----------- -----------  ----------- 
<S>                        <C>         <C>          <C>
SALES 
First ....................   $ 99,740    $ 90,594     $ 77,985 
Second ...................    107,423      96,438       84,141 
Third ....................    106,633      94,061       84,157 
Fourth ...................    116,020     100,373       90,639 
                           ----------- -----------  ----------- 
 Year ....................   $429,816    $381,466     $336,922 
                           =========== ===========  =========== 

GROSS PROFIT 
First ....................   $ 23,837    $ 19,965     $ 19,007 
Second ...................     25,941      22,723       21,073 
Third ....................     27,605      22,608       19,775 
Fourth ...................     30,093      27,665       17,240 
                           ----------- -----------  ----------- 
 Year ....................   $107,476    $ 92,961     $ 77,095 
                           =========== ===========  =========== 
NET LOSS 
First ....................   $ (2,165)   $ (5,135)    $ (3,436) 
Second ...................    (10,192)     (3,225)      (3,783) 
Third ....................     (1,808)     (4,125)      (4,669) 
Fourth ...................       (549)     (5,369)      (6,170) 
                           ----------- -----------  ----------- 
 Year ....................   $(14,714)   $(17,854)    $(18,058) 
                           =========== ===========  =========== 
NET LOSS PER COMMON SHARE 
 (BASIC AND DILUTED) 
First ....................   $   (.21)   $   (.50)    $   (.34) 
Second ...................      (1.01)       (.32)        (.37) 
Third ....................       (.18)       (.41)        (.46) 
Fourth ...................       (.05)       (.54)        (.60) 
                           ----------- -----------  ----------- 
 Year ....................   $  (1.45)   $  (1.77)    $  (1.77) 
                           =========== ===========  =========== 
</TABLE>

                               33           
<PAGE>
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
        FINANCIAL DISCLOSURE 

   None. 

                               34           
<PAGE>
                                   PART III 

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT. 

DIRECTORS AND OFFICERS 

   The following table sets forth the directors and executive officers of the 
Company: 

<TABLE>
<CAPTION>
 NAME                 AGE                       POSITION 
- -------------------  ----- ------------------------------------------------- 
<S>                  <C>   <C>
Anthony J. Cuti.....   52   Chairman, Chief Executive Officer and President 
William Tennant.....   50   Senior Vice President and Chief Financial Officer 
Gary Charboneau.....   53   Senior Vice President--Sales and Merchandising 
Jerry M. Ray........   50   Senior Vice President--Store Operations 
Nicole S. Arnaboldi.   39   Director 
David L. Jaffe......   39   Director 
Andrew J. Nathanson.   40   Director 
Kevin Roberg........   46   Director 
David W. Johnson ...   65   Director 
</TABLE>

   Anthony J. Cuti has been Chairman and Chief Executive Officer of the 
Company since April 1996. Prior to joining the Company, Mr. Cuti served as 
President and as a member of the Board of Directors of Supermarkets General 
and Pathmark from 1993 to 1996 and, prior to being named President of 
Supermarkets General and Pathmark, Mr. Cuti was Executive Vice President and 
Chief Financial Officer of Supermarkets Generals. From 1984 to 1990, he was 
the Chief Financial Officer of the Bristol-Myers International Group of the 
Bristol-Myers Company and prior to that was employed by the Revlon 
Corporation. 

   William Tennant has been Senior Vice President and Chief Financial Officer 
of the Company since February 1997. Prior to joining the Company, Mr. Tennant 
was Senior Vice President and Chief Financial Officer of Tops Appliance City, 
a consumer electronics retailer, from 1993 to 1996. From 1986 to 1993, Mr. 
Tennant served as Vice President and Controller for the Great Atlantic & 
Pacific Tea Company. 

   Gary Charboneau has been Senior Vice President in charge of Sales and 
Merchandising of the Company since February 1993. Prior to joining the 
Company, Mr. Charboneau held various positions at CVS, a retail drugstore 
chain, from 1978 to February 1993, most recently as Executive Vice President. 

   Jerry M. Ray has been Senior Vice President in charge of Store Operations 
since July 1996 and served as Vice President of Pharmacy Operations from 
April 1995 to June 1996. From 1991 to 1994, Mr. Ray served as President and 
CEO of Begley Drugstores, Inc. 

   Nicole S. Arnaboldi has been a Director of the Company since June 1997. 
Ms. Arnaboldi is a Managing Director of DLJMB. She joined the DLJ Merchant 
Banking Group in March 1993 after six years with The Sprout Group, DLJ's 
venture capital affiliate. 

   David L. Jaffe has been a Director of the Company since June 1997. Mr. 
Jaffe is a Managing Director of DLJMB. Mr. Jaffe joined DLJ Merchant Banking 
in 1984 and became a Managing Director in 1995. He currently sits on the 
Board of Directors of each of EZ Buy and EZ Sell Recycler Corporation, OHA 
Financial, Inc., OSF, Inc., Terra Nova Group, Pharmaceutical Fine Chemicals 
SA and Brand Scaffold Services, Inc. 

   Andrew J. Nathanson has been a Director of the Company since June 1997. 
Mr. Nathanson is a Managing Director of DLJ. Mr. Nathanson joined DLJ in 1989 
from Drexel Burnham Lambert, and has been a Managing Director of DLJ since 
1991. Mr. Nathanson also serves on the Board of Directors of Specialty Foods, 
Inc. 

   Kevin Roberg has been a Director of the Company since February 1998. Mr. 
Roberg currently serves as Chief Executive Officer and President of ValueRx. 
Prior to serving in this position, Mr. Roberg served as Chief Executive 
Officer and President of Medintell Systems Corporation during 1995 and as 

                               35           
<PAGE>
President--Western Health Plans and President--PRIMExtra, Inc. for EBP Health 
Plans, Inc. from 1994 to 1995. Mr. Roberg served as President-Self Funded and 
Private Label Division from 1993 to 1993 for Diversified Pharmaceutical 
Services (a subsidiary of United HealthCare Corporation) ("Diversified") and 
prior to that served as Chief Operating Officer of Diversified. 

   David W. Johnson has been a Director of the Company since February 1998. 
Since 1993, Mr. Johnson has served as Chairman of the Board of Campbell Soup 
Company. Prior to holding this position, Mr. Johnson served as President and 
Chief Executive Officer of Campbell Soup Company. Mr. Johnson also serves on 
the Board of Directors of Colgate Palmolive Company. 

COMMITTEES OF THE BOARD OF DIRECTORS 

   The members of the Compensation Committee are Messrs. Jaffe and Johnson. 
The duties of the Compensation Committee are to provide a general review of 
the Company's compensation and benefit plans to ensure that they meet 
corporate objectives. In addition, the Compensation Committee will review 
management's recommendations on (i) compensation of all officers of the 
Company and (ii) adopting and changing major Company compensation policies 
and practices, and report its recommendations to the entire Board of 
Directors for approval and authorization. The Compensation Committee will 
administer the Company's stock plans. 

   The Board of Directors may also establish other committees to assist in 
the discharge of its responsibilities. 

                               36           
<PAGE>
ITEM 11. EXECUTIVE COMPENSATION 

                          SUMMARY COMPENSATION TABLE 

   The following table summarizes the principal components of compensation of 
the Chief Executive Officer and the other four highest compensated executive 
officers of the Company (the "Named Executive Officers") for the fiscal year 
ended December 27, 1997. The compensation set forth below fully reflects 
compensation for services performed on behalf of the Company and its 
subsidiaries. 

<TABLE>
<CAPTION>
                                                                                  LONG-TERM 
                                                 ANNUAL COMPENSATION            COMPENSATION 
                                      ---------------------------------------- -------------- 
                                                                                 SECURITIES 
NAME AND                      FISCAL                             OTHER ANNUAL    UNDERLYING      ALL OTHER 
PRINCIPAL POSITIONS            YEAR       SALARY       BONUS     COMPENSATION    OPTIONS(#)     COMPENSATION 
- ---------------------------  -------- ------------  ---------- --------------  -------------- -------------- 
<S>                          <C>      <C>           <C>        <C>             <C>            <C>
Anthony J. Cuti.............   1997      $386,000    $475,000        $--           496,569          $-- 
 Chief Executive Officer 
Gary Charboneau.............   1997       243,000     121,600         --           141,877           -- 
 Senior Vice 
 President--Sales 
 and Merchandising 
Jerry M. Ray................   1997       200,000     100,000         --           118,231           -- 
 Senior Vice 
 President--Store 
 Operations 
William J. Tennant..........   1997       151,000(1)   61,300         --           115,393           -- 
 Senior Vice 
 President--Chief 
 Financial Officer 
Joseph S. Lacko.............   1997       150,000      52,500         --            11,823           -- 
 Vice President--Management 
 Information Systems 

</TABLE>

- ------------ 
(1)     Reflects Mr. Tenant's salary for the partial year from February 18, 
        1997 (when he joined the Company) through December 27, 1997. 

                               37           
<PAGE>
                      OPTION GRANTS IN LAST FISCAL YEAR 

   The following table discloses options granted during fiscal year 1997 to 
the Named Executive Officers. 

<TABLE>
<CAPTION>
                                            INDIVIDUAL GRANTS 
                       ----------------------------------------------------------- 
                                                                                    POTENTIAL REALIZABLE VALUE 
                         NUMBER OF     % OF TOTAL                                               AT 
                        SECURITIES      OPTIONS                                    ASSUMED RATES OF STOCK PRICE 
                        UNDERLYING     GRANTED TO    EXERCISE OR                      APPRECIATION FOR OPTION 
                          OPTIONS     EMPLOYEES IN    BASE PRICE     EXPIRATION               TERM(2) 
                        GRANTED(1)    FISCAL YEAR     PER SHARE         DATE                                     
   ----------------------------------------------------------------------------------------------------------------- 
                            5%            10% 
                       ------------ -------------- 
<S>                    <C>          <C>               <C>          <C>              <C>            <C>
Anthony J. Cuti.......    496,569         45.5%         $8.33          6/18/07      $2,602,022     $6,594,436 
Gary Charboneau(3) ...    141,877         13.0           8.33          6/18/07         743,435      1,884,127 
Jerry M. Ray(3).......    118,231         10.8           8.33          6/18/07         619,530      1,570,081 
William J. Tennant(4).    115,393         10.6        7.34-8.33    2/18/07-6/18/07     561,964(5)   1,425,104(5) 
Joseph S. Lacko.......     11,823          1.1           8.33          6/18/07          61,953        157,009 
</TABLE>

- ------------ 
(1)     Except for 68,101 options grated to Mr. Tennant under a separate 
        program, all of such options vest fully on the eighth anniversary of 
        the grant date and may vet sooner based on the Company's achievement 
        of certain specified targets. 
(2)     Amounts reflect certain assumed rates of appreciation for the term of 
        the option as set forth in the executive compensation disclosure 
        rules of the Securities and Exchange Commission and are not intended 
        to forecast future appreciation of the Common Stock. Actual gains, if 
        any, on stock option exercises depend on future performance of the 
        Company's stock and overall market conditions. For each Named 
        Executive Officer other than Mr. Tennant, at an annual rate of 
        appreciation of 5% per year for the option term, the price of the 
        Common Stock would be approximately $13.57 per share as of the 
        expiration date, and for Mr. Tennant such price would be 
        approximately $12.62 per share. For each Named Executive Officer 
        other than Mr. Tennant, at an annual rate of appreciation of 10% per 
        year for the option term, the price of the Common Stock would be 
        approximately $21.61 per share as of the expiration date, and for Mr. 
        Tennant such price would be approximately $20.10 per share. 
(3)     All of such options were granted under the Equity Plan (as defined 
        below). The options granted under such plan are subject to repurchase 
        provisions upon termination of employment. See "--Stock Options." 
(4)     68,101 of Mr. Tennant's options were granted pursuant to a separate 
        program with the Company, and the remaining 47,292 options were 
        granted pursuant to the Equity Plan. 
(5)     Amounts for Mr. Tennant are calculated based on a weighted average 
        exercise price of $7.75 per share. 

                               38           
<PAGE>
                        FISCAL YEAR END OPTION VALUES 

   The following table summarizes the number and value of all unexercised 
options held by the Named Executive Officers at the end of 1997. There were 
no options exercised in the Company's last fiscal year. 

<TABLE>
<CAPTION>
                                                  NUMBER OF 
                                                  SECURITIES 
                                                  UNDERLYING    VALUE OF UNEXERCISED 
                                                 UNEXERCISED    IN-THE-MONEY OPTIONS 
                      SHARES                       OPTIONS       AT FISCAL YEAR END 
NAME                 ACQUIRED   VALUE REALIZED FISCAL YEAR END         ($)(1) 
- ------------------  ---------- --------------  --------------- --------------------- 
                                                 EXERCISABLE/       EXERCISABLE/ 
                                                UNEXERCISABLE       UNEXERCISABLE 
<S>                 <C>        <C>             <C>             <C>
Anthony J. Cuti ...     --            --       409,931/451,168      $2,825,108/0 
Gary Charboneau ...     --            --        68,985/128,905         306,443/0 
Jerry M. Ray.......     --            --        55,842/107,421         285,161/0 
William J. Tennant.     --            --        72,425/42,968           67,420/0 
Joseph S. Lacko ...     --            --         18,917/9,931          131,944/0 
</TABLE>

- ------------ 
(1)     Assumes the value of the Common Stock as of December 27, 1997 is 
        equal to $8.33 per share. 

   Mr. Barry Weston, the Company's former Chief Executive Officer, resigned 
from the Company effective as of February 28, 1997. In connection with Mr. 
Weston's severance from the Company and the Recapitalization, Mr. Weston 
received approximately $1.6 million from DLJMB and all of his unexercised 
options were effectively canceled. In addition, Mr. Weston received 
approximately $412,000 from the Company during 1997, a portion of which was 
attributable to his 1995 and 1996 bonus and the remainder of which was 
attributable to severance payments. 

COMPENSATION OF DIRECTORS 

   Directors of the Company who are employees of the Company, DLJ or DLJMB or 
their respective subsidiaries are not compensated for serving as directors. 
As of the date of their election to the Board of Directors, each of Messrs. 
Roberg and Johnson received 5,000 options to purchase Common Stock at 
$21.5625 per share. The Company plans to compensate future Directors who are 
not employees of the Company, DLJ or DLJMB ("Non-Employee Directors") with 
option grants for serving in such capacity and for serving on committees of 
the Board of Directors and to reimburse Non-Employee Directors for 
out-of-pocket expenses incurred in such capacity. 

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION 

   Prior to the consummation of its initial public offering, the Company did 
not have a compensation committee. Instead, compensation decisions regarding 
the Company's executive officers were made by the Board of Directors. Each 
executive officer of the Company has an employment agreement with the Company 
that establishes his annual compensation. See "--Employment Agreements." 

EMPLOYMENT AGREEMENTS 

   Effective June 18, 1997, the Company entered into an employment agreement 
with Anthony J. Cuti (the "Cuti Employment Agreement"). Pursuant to the Cuti 
Employment Agreement, Mr. Cuti serves as Chairman, President and Chief 
Executive Officer of the Company. The Cuti Employment Agreement provides for 
(i) a base salary of $425,000 per year, which will increase to $500,000 in 
1998 and 550,000 in 1999 if certain EBITDA targets (as defined in the Cuti 
Employment Agreement) are met and will increase every 18 months commencing 
July 1, 2001 by not less than the percentage increase in a designated 
consumer price index for such 18-month period, (ii) an annual incentive bonus 
of up to 200% of base salary based on certain EBITDA targets and (iii) 
participation in all benefit plans generally available to executive officers 
of the Company. 

   Pursuant to the Cuti Employment Agreement and the Equity Plan described 
below, on June 18, 1997, Mr. Cuti was granted non-qualified stock options to 
purchase an aggregate of 496,569 shares of Common 

                               39           
<PAGE>
Stock at an exercise price of $8.33 per share. Subject to Mr. Cuti's 
continued employment with the Company, the options generally will become 100% 
vested on the eighth anniversary of the date of grant, but may vest sooner 
based on the Company's achievement of certain specified financial targets. 
Furthermore, the vesting of options will accelerate upon the occurrence of a 
sale of the Company (as defined in the Cuti Employment Agreement) on or prior 
to December 30, 2001, based on the Company's achievement of specified 
financial targets prior to the date of any such sale of the Company. 

   The Cuti Employment Agreement provides that Mr. Cuti may generally only 
transfer up to 10% of his shares of Common Stock in each calendar year while 
he is an employee of the Company, except pursuant to certain rights and 
obligations (i) to transfer ("put") his shares to the Company upon 
termination of employment and (ii) to transfer shares in connection with 
certain transfers of Common Stock by DLJMBPII. The Cuti Employment Agreement 
also provides that Mr. Cuti will be given the opportunity to invest 
additional amounts in stock of the Company in the event that DLJMBPII invests 
new equity in the Company or creates an instrument that may be dilutive to 
Mr. Cuti's equity position relative to DLJMBPII. 

   Mr. Cuti's initial term of employment is for three years and, unless 
terminated by notice of non-renewal by either the Company or Mr. Cuti, will 
continue thereafter for successive one-year periods. Pursuant to the Cuti 
Employment Agreement, if the Company terminates Mr. Cuti without "cause" (as 
defined in the Cuti Employment Agreement) or by notice of non-renewal or Mr. 
Cuti resigns with "good reason" (as defined in the Cuti Employment 
Agreement), Mr. Cuti will be entitled to continued base salary and incentive 
bonus payments (at the rate of two times base salary and bonus for the year 
prior to termination, which can be increased to three times base salary and 
bonus upon the occurrence of certain events, including a sale of the Company) 
and employee benefits for a two year period, which, under certain 
circumstances, including Mr. Cuti's termination of employment prior to June 
18, 2003 and within one year following a sale of the Company, may be extended 
by one year. Additionally, the vesting of Mr. Cuti's options may accelerate 
upon such a termination of employment, based on the Company's financial 
performance prior to such termination and whether a sale of the Company has 
occurred. The Cuti Employment Agreement also contains certain non-compete, 
non-solicitation and confidentiality provisions. See also "Certain 
Relationships and Related Transaction--Cuti Loan Agreement." 

   The Company has also entered into agreements with Messrs. Charboneau and 
Ray and certain other executives that provide for their initial base salary 
as well as annual incentive bonuses based on certain EBITDA targets. Mr. 
Charboneau's employment agreement provides for an annual base salary of 
$220,000 and for additional increases from time to time as the Company may 
determine. Mr. Ray's employment agreement provides for an annual base salary 
of $150,000 and for additional increases from time to time as the Company may 
determine. Each of Messrs. Charboneau and Ray are entitled to severance 
payments equaling 12 months of their respective salaries if they are 
terminated without "cause" (as respectively defined in the agreements). 

   The Company's agreement with Mr. Lacko provides for payment of an annual 
base salary of $150,000 as well as for payment of annual incentive bonuses 
based upon achievement of certain corporate and financial objectives. Mr. 
Lacko's agreement also provides for the grant of stock options to acquire an 
aggregate of 6,805 shares of Common Stock. These options vested on June 18, 
1997 and have an exercise price of $8.33 per share. In addition, Mr. Lacko's 
agreement provides for 12 months of salary continuation in the event Mr. 
Lacko is terminated without cause. 

   The Company's agreement with Mr. Tennant provides for payment of an annual 
base salary of $175,000 per year as well as for payment of annual incentive 
bonuses based upon achievements of certain financial targets. Mr. Tennant's 
agreement also provides for the grant of stock options to acquire an 
aggregate of 68,101 shares of Common Stock at an exercise price of $7.34 per 
share. These options vested on June 18, 1997. The agreement also provides for 
12 months of salary continuation in the event Mr. Tennant is terminated 
without cause. 

SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN 

   The Company has established the Supplemental Executive Retirement Plan 
("SERP"), an unfunded retirement plan that provides a lump sum benefit equal 
to the actuarial present value of a life annuity 

                               40           
<PAGE>
commencing at the later of age 65 or termination of employment for any reason 
other than for "cause." The SERP benefit is calculated as a percentage of a 
participant's Final Average Earnings (defined as the average base salary and 
bonus for the five years which produce the greatest amount multiplied by the 
participant's years of services with the Company). Currently, Mr. Cuti is the 
only SERP participant. Mr. Cuti's estimated SERP benefit, based on his 
annualized 1996 includable compensation and upon discount rates effective for 
termination of employment in December 1997, is estimated to be $619,000, if 
termination of employment occurs after 10 years when Mr. Cuti will be age 
60-1/2, or $1,263,000 if termination of employment occurs after 14-1/2 years, 
when Mr. Cuti will be age 65. Pursuant to the Cuti Employment Agreement, the 
Company is required to set aside funds in a "rabbi trust" to pay Mr. Cuti's 
SERP benefit in specified circumstances, including a sale of the Company, 
termination without "cause" and resignation for "good reason" (as 
respectively defined in the Cuti Employment Agreement). Furthermore, in the 
event of his termination without "cause" or by reason of the Company's 
non-renewal, his resignation for "good reason," or his death or disability, 
Mr. Cuti's SERP benefit will be calculated on the basis of 20 years of 
employment regardless of his actual number of years of employment with the 
Company (the present value of which was approximately $700,000 as of December 
27, 1997). 

STOCK OPTIONS 

   1992 Stock Option Plan. The Board of Directors adopted and the Company's 
stockholders approved the 1992 Stock Option Plan (the "1992 Plan") in 
September 1992. Under the 1992 Plan, the Board of Directors may grant to 
executive and other key employees of the Company nonqualified stock options 
to purchase up to an aggregate of 510,757 shares of Common Stock of the 
Company at exercise prices and terms specified by the Board of Directors. 

   At December 27, 1997, there were outstanding nonqualified stock options 
issued under the 1992 Plan to purchase up to an aggregate of 281,657 shares 
of Common Stock of the Company at exercise prices ranging from $0.58 to 
$40.88 per share. The 1992 Plan was frozen as to the future grants following 
the initial public offering of the Company's Common Stock. All options issued 
under the 1992 Plan are 100% vested. 

   1997 Equity Participation Plan. As of June 18, 1997, the Board of 
Directors and stockholders of the Company approved the 1997 Equity 
Participation Plan (the "Equity Plan"). Since consummation of the initial 
public offering of the Company's Common Stock, the Equity Plan has been 
administered by the Compensation Committee. The Board of Directors is 
authorized under the Equity Plan to select the individuals to whom awards 
will be made (the "Participants") and determine the terms and conditions of 
the awards under the Equity Plan. The Equity Plan provides that the Board of 
Directors may grant or issue stock options, stock appreciation rights, 
restricted stock, deferred stock, dividend equivalents, performance awards, 
stock payments, and other stock related benefits, or any combination thereof, 
to any eligible employee or consultant. Each such award will be set forth in 
a separate a agreement with the person receiving the award and will indicate 
the type, terms, and conditions of the award. An aggregate of 1,321,181 
shares of Common Stock of the Company have been reserved for issuance under 
the Equity Plan, subject to certain adjustments reflecting changes in the 
Company's capitalization. The Equity Plan provides that no Participant may 
receive awards relating to more than 480,429 shares of Common Stock per year. 

   Section 162(m) Limitation. In general, under Section 162(m) of the Code 
("Section 162(m)"), income tax deductions of publicly-held corporations may 
be limited to the extent total compensation including base salary, annual 
bonus, stock option exercises and non-qualified benefits for certain 
executive officers exceeds $1 million (less the amount of any "excess 
parachute payments" as defined in Section 280G of the Code) in any one year. 
Under a Section 162(m) transition rule for compensation plans of corporations 
which are privately held and which become publicly held in an initial public 
offering, the Equity Plan will not be subject to Section 162(m) until the 
"Transition Date" which is defined as the earliest of (i) the material 
modification of the Equity Plan; (ii) the issuance of all Common Stock and 
other compensation that has been allocated under the Equity Plan; and (iii) 
the first meeting of stockholders at which directors are to be elected that 
occurs after December 31, 2001. After the Transition Date, rights and awards 
granted under the Equity Plan will not qualify as "performance-based 

                               41           
<PAGE>
compensation" for purposes of Section 162(m) unless such rights and awards 
are granted by an independent compensation committee, and such awards are 
granted or vest upon pre-established objective performance goals, the 
material terms of which are disclosed to and approved by the stockholders of 
the Company. The transition rule will also apply to base salary and bonus 
payments made pursuant to employment agreements in effect at the time of the 
initial public offering of the Company's Common Stock. 

   The Board of Directors generally will have the power and authority to 
amend the equity Plan at any time without approval of the Company's 
stockholders, subject to applicable federal securities and tax law 
limitations (including rules and regulations of the New York Stock Exchange). 

                               42           
<PAGE>
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS 
         AND MANAGEMENT 

   The following table sets forth certain information with respect to the 
beneficial ownership (as defined by the regulations of the Securities and 
Exchange Commission) of the Company's Common Stock (which constitutes the 
only class of voting capital stock of the Company) by (i) each person known 
to the Company to be the beneficial owner of 5% or more of the Common Stock, 
(ii) each director, (iii) each Named Executive Officer and (iv) all executive 
officers and directors as a group, based on data as of March 15, 1998. 

<TABLE>
<CAPTION>
                                                 SHARES BENEFICIALLY OWNED 
                                                            (1) 
                                                 -------------------------- 
NAME                                              NO. OF SHARES    PERCENT 
- -----------------------------------------------  --------------- --------- 
<S>                                              <C>             <C>
DLJ Merchant Banking Partners II, L.P. 
 and related investors(2).......................    8,292,162       48.9% 
Anthony J. Cuti.................................      409,931        2.4% 
David L. Jaffe(3)...............................           --         -- 
Nicole S. Arnaboldi(3)..........................           --         -- 
Andrew J. Nathanson(3)..........................           --         -- 
Gary Charboneau.................................      272,436        1.6% 
Jerry M. Ray....................................       96,532           * 
William J. Tennant..............................       72,425           * 
Joseph S. Lacko.................................       18,917           * 
Kevin Roberg....................................        5,000           * 
David W. Johnson................................        5,000           * 

All executive officers and directors as a group 
 (10 persons)(3)................................      861,324        4.9 
</TABLE>

- ------------ 
*       Less than one percent 
(1)     For purposes of this table, a person is deemed to have "beneficial 
        ownership" of any shares that such person has the right to acquire 
        within 60 days after the date of this Prospectus. For purposes of 
        calculating the percentage of outstanding shares held by each person 
        named above, any shares that such person has the right to acquire 
        within 60 days after the date of this prospectus are deemed to be 
        outstanding, but not for the purposes of calculating the percentage 
        ownership of any other person. 
(2)     Consists of shares held directly by the following related investors, 
        each of whom is affiliated with DLJ: DLJ Merchant Banking Partners 
        II, L.P. ("DLJMBPII"), 5,223,192 shares; DLJ Merchant Banking 
        Partners II-A, L.P. ("DLJMBPII-A"), 208,012 shares; DLJ Offshore 
        Partners II, C.V. ("DLJOPII"), 256,849 shares; DLJ Diversified 
        Partners, L.P. ("DLJ"), 305,371 shares; DLJ Diversified Partners-A, 
        L.P. ("DLJDPA"), 113,405 shares; DLJMB Funding II, Inc. ("DLJMBFII"), 
        927,352 shares; DLJ Millennium Partners, L.P. ("Millennium"), 84,453 
        shares; DLJ Millennium-A, L.P.: ("Millennium-A"), 16,471 shares; DLJ 
        EAB Partners, L.P. ("DLJEAB"), 23,452 shares; UK Investment Plan 1997 
        Partners ("UK Investment"), 138,196 shares; and DLJ First ESC L.P. 
        ("DLJ ESC" and, collectively with the aforementioned entities, the 
        "DLJMBPII Entities") 995,009 shares. See "Certain Relationships and 
        Related Transactions--DLJMB Relationships." The address of each 
        DLJMBPII, DLJMBIIA, DLJDP, DLJDPA, DLJMBFII, Millennium, 
        Millennium-A, DLJEAB, and DLJ ESC is 277 Park Avenue, New York, New 
        York 10172. The address of DLJOPII is c/o John B. Gorsiraweg, 14 
        Willemstad, Curacao, Netherlands Antilles. The address of UK 
        Investment is 2121 Avenue of the Stars, Fox Plaza, Suite 3000, Los 
        Angeles, California 90067. As a general partner of each of DLJMBPII, 
        DLJMBIIA, DLJOPII, DLJDP, DLJDPA, DLJEAB, Millennium and 
        Millennium-A, DLJMB may be deemed to beneficially own indirectly all 
        of the shares held directly by DLJMBPII, DLJMBIIA, DLJOPII, DLJDP, 
        DLJDPA, DLJEAB, Millennium and Millennium-A, and as the parent of 
        each of DLJMB, DLJMBFII and DLJLBO Plans Management Corporation (the 
        General partner of DLJ ESC and UK Investment), Donaldson, Lufkin & 
        Jenrette Inc., the parent of DLJ ("DLJ Inc.") may be deemed to 
        beneficially own indirectly all of the shares held by DLJMBPII, 
        DLJMBIIA, DLJOPII, DLJDP, DLJDPA, DLJEAB, Millennium, Millennium-A, 
        DLJMBFII, DLJESC and UK investment. The address of DLJ Merchant 
        Banking, Inc. is 277 Park Avenue, New York, New York 10172. 
(3)     Mr. Nathanson is a Managing Director of DLJ and, as a result may be 
        deemed to beneficially own the shares of Common Stock held by the 
        DLJMBPII Entities. Mr. Nathanson expressly disclaims beneficial 
        ownership of such shares of Common Stock. Ms. Arnaboldi and Mr. Jaffe 
        are managing directors of DLJMB and DLJ Diversified Partners, Inc. 
        ("DLJDPI"). DLJMB is the managing general partner of DLJMBII, 
        DLJMBIIA, DLJOPII, Millennium and Millennium-A. DLJDPI is the 
        managing general partner of DLJDP and DLJDPA. As a result, Ms. 
        Arnaboldi and Mr. Jaffe may be deemed to beneficially own the shares 
        of Common Stock held by each of DLJMBPII, DLJMBIIA, DLJOPII, DLJDP, 
        DLJDPA, Millennium, Millennium-A. Ms. Arnaboldi and Mr. Jaffe 
        expressly disclaim beneficial ownership of such shares of Common 
        Stock. 

                               43           
<PAGE>
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 

DLJMB RELATIONSHIPS 

   In connection with the Recapitalization, DLJMBPII and certain of its 
affiliates (the "DLJ Entities") purchased an aggregate of 9,383,420 shares of 
Common Stock, certain members of management retained an aggregate of 284,832 
shares of Common Stock and certain other stockholders retained an aggregate 
of 589,577 shares of Common Stock. The aggregate purchase price for the 
shares acquired by the DLJ Entities was approximately $78.7 million or 
approximately $8.33 per share. Each of these shareholders other than members 
of management signed the Stockholders and Registration Rights Agreement. See 
"--Stockholders and Registration Rights Agreement." Mr. Jaffe and Ms. 
Arnaboldi, directors of the Company, are managing Directors of DLJMB, and Mr. 
Nathanson, also a director of the Company, is a Managing Director of DLJ. 

   On September 30, 1997, the Company entered into a credit agreement (the 
"Old Existing Credit Agreement") in which DLJ Capital Funding, Inc., an 
affiliate of DLJMBPII, ("DLJ Funding") acted as the arranger and syndication 
agent. In connection with the Old Credit Agreement, DLJ Funding received a 
customary funding fee of approximately $2.4 million. On February 13, 1998, 
the Company entered into its existing credit agreement (the "Existing Credit 
Agreement") for which DLJ Funding acted as the manager and syndication agent. 
In connection with the Existing Credit Agreement, DLJ Funding received a 
customary funding fee of approximately $1.9 million. 

   DLJ (an affiliate of DLJMBPII) acted as financial advisor to the Company 
in connection with the structuring of the Recapitalization and received 
customary fees for such services of approximately $3.5 million and 
reimbursement for reasonable out-of-pocket expenses and affiliates of DLJ 
received standby commitment fees of approximately $1.2 million in connection 
with change of control offers for the Zero Coupon Notes and the Senior Notes, 
which were required as a result of the Recapitalization. The Company agreed 
to indemnify DLJ in connection with its acting as financial advisor. In 
addition, DLJ received its pro rata portion of the underwriters compensation 
(approximately $4.258 million) in connection with its services as lead 
underwriter in the initial public offering of the Company's Common Stock that 
was consummated on February 13, 1998. DLJ also served as sole underwriter in 
connection with the offering of the Company's 9 1/4% Senior Subordinated 
Notes due 2008 that was consummated on February 13, 1998, for which DLJ 
received $2.4 million of underwriting compensation payable in connection 
therewith and $50,000 in connection with services relating to the defeasance 
of the Zero Coupon Notes and the Senior Notes. In addition, the DLJ Entities 
received $16.75 million from the sale of 1,091,658 shares of Common Stock in 
connection with the exercise by the Underwriters of their overallotment 
option in connection with the initial public offering of the Company's Common 
Stock. 

CUTI LOAN AGREEMENT 

   Pursuant to the terms of the Cuti Employment Agreement and a Secured Loan 
Agreement and related agreements among Mr. Cuti, the Company and DLJ (the 
"Loan Documents"), on November 20, 1997, Mr. Cuti borrowed $1 million from 
DLJ (the "Loan"). The Loan is secured by Mr. Cuti's pledge to DLJ of his 
options granted under the equity Plan and his option to purchase 496,569 
shares of Common Stock, and all Common Stock and other proceeds payable upon 
exercise or other disposition thereof (the "Pledged Security"). The Loan is 
subject to interest at the Federal Mid-Term Rate as in effect from time to 
time and is generally payable in five equal installments commencing within 30 
days after Mr. Cuti has the ability to receive cash in exchange for any of 
the Pledged Security. In addition, the Company may apply any amounts to which 
Mr. Cuti is entitled upon termination of employment to repayment of the Loan. 
The Cuti Employment Agreement and the Loan Documents further provide that in 
the event of termination of Mr. Cuti's employment by reason of termination by 
the Company without "cause" or the Company's non-renewal or his resignation 
with "good reason" (as such terms are defined in the Cuti Employment 
Agreement), the Company will reimburse Mr. Cuti for all interest accrued as 
of the date of such termination if the Company has achieved certain specified 
financial targets for the year prior to termination and the year of such 
termination. The Loan Documents permits DLJ to assign the Loan to certain of 
its affiliates, including the Company, and the Company is obligated pursuant 
to the Cuti Employment Agreement to assume the Loan from DLJ as soon as 
practicable after the Company and DLJ agree that the Company may do so. At 
December 27, 1997, DLJ had not exercised such election. 

                               44           
<PAGE>
OTHER RELATIONSHIPS 

   The Company incurred aggregate fees owing to Credit Suisse First Boston 
for financial services rendered from March 1995 through the consummation of 
the Recapitalization in the aggregate among of $3.6 million, of which $1.4 
million was paid upon consummation of the Recapitalization and the remaining 
$2.2 million was paid in connection with the consummation of the initial 
public offering of the Company's Common Stock. 

STOCKHOLDERS AND REGISTRATION RIGHTS AGREEMENT 

   In connection with the Recapitalization, certain of the shareholders of 
the Company (the "Initial Shareholders") entered into a Stockholders and 
Registration Rights Agreement, pursuant to which the Company has granted the 
Initial Shareholders the right to cause the Company to register shares of 
Common Stock (the "registrable securities") under the Securities Act. Upon 
consummation of the Offering, 9,395,278 outstanding shares of Common Stock 
will constitute registrable securities and therefore will be eligible for 
registration pursuant to the Stockholders and Registration Rights Agreement. 
Under the terms of the Stockholders and Registration Rights Agreement, at any 
time after the one year anniversary date of the Offering, (i) the holders of 
at least a majority of the registrable securities held by the DLJ Entities 
can require the Company, subject to certain limitations, to file a 
registration statement under the Securities Act covering all or part of the 
registrable securities held by the DLJ Entities and (ii) the remaining 
Initial Shareholders can require the Company, subject to certain limitations, 
to file a registration statement covering all or part of the registrable 
securities held by such Initial Shareholders (each, a "demand registration"). 
The Company is obligated to pay all registration expenses (other than 
underwriting discounts and commissions and subject to certain limitations) 
incurred in connection with the demand registrations. In addition, the 
Stockholders and Registration Rights Agreement provides the Initial 
Shareholders with "piggyback" registration rights, subject to certain 
limitations, whenever the Company files a registration statement on a 
registration form that cam be used to register securities held by such 
Initial Shareholders. 

                               45           
<PAGE>
                                   PART IV 

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K. 

    (a) The following documents are filed as a part of this report: 

         (i)  Financial Statements 
         (ii) Exhibits: 

EXHIBIT NO.                             DESCRIPTION 
- -----------                             ----------- 
3.1(i)            Amended and Restated Certificate of Incorporation of the
                  Company (incorporated by reference to Exhibit 3.1(i ) to the
                  Common Stock S-1).
3.1(ii)           Form of Amended and Restated Bylaws of the Company
                  (incorporated by reference to Exhibit 3.1(i) to the Common
                  Stock S-1).
3.2(i)            Certificate of Incorporation of DRI I Inc. (incorporated by
                  reference to Exhibit 3.2(i) to the S-1 with respect to the
                  Company's 9 1/4% Senior Subordinated Notes due 2008 (the
                  "Notes S-1")).
3.2(ii)           By-laws of DRI I Inc. (incorporated by reference to Exhibit
                  3.2(ii) of the Notes S-1)
3.3               Second Amended and Restated Partnership Agreement of Duane
                  Reade. (incorporated by reference to Exhibit 3.3 of the Notes
                  S-1)
4.1               Form of Indenture. (incorporated by reference to Exhibit 4.1
                  of the Notes S-1)
10.1              Duane Reade Inc. 1997 Equity Participation Plan (incorporated
                  by reference to Exhibit 10.1 to the Company's Form S-1
                  registration Statement (File No. 333-41239), the "Common
                  Stock S-1").
10.2              Duane Read Inc. Holding Corp. 1992 Stock Incentive Plan
                  (incorporated by reference to Exhibit 10.2 to the Common
                  Stock S-1).
10.3              Employment Agreement, dated as of October 27, 1997, between
                  the Company and Anthony J. Cuti (incorporated by reference to
                  Exhibit 10.3 to the Common Stock S-1).
10.4              Employment Agreement, dated as of February 22, 1993, as
                  amended, between the Company and Gary Charboneau
                  (incorporated by reference to Exhibit 10.4 to the Common
                  Stock S-1).
10.5              Employment Agreement, dated as of April 10, 1995, as amended,
                  between Duane Reade and Jerry M. Ray (incorporated by
                  reference to Exhibit 10.5 to the Common Stock S-1).
10.6              Employment Letter Agreement, dated as of October 9, 1996,
                  between Duane Read and Joseph Lacko (incorporated by
                  reference to Exhibit 10.6 to the Common Stock S-1).
10.7              Employment Letter Agreement, dated as of February 12, 1997,
                  between the Company and William Tennant (incorporated by
                  reference to Exhibit 10.7 to the Common Stock S-1).
10.8              Agreement, dated as of November 22, 1996 between Duane Reade
                  and Drug, Chemical, Cosmetic, Plastics and Affiliated
                  Industries Warehouse Employees Local 815 (incorporated by
                  reference to Exhibit 10.8 to the Common Stock S-1).
10.9              Agreement, dated July 16, 1992, as amended, between Duane
                  Reade and Allied Trades Council (incorporated by reference to
                  Exhibit 10.9 to the Common Stock S-1).
10.10             Agreement, dated February 4, 1997, as amended between Duane
                  Reade and The Pharmacy fund, Inc. (incorporated by reference
                  to Exhibit 10.10 to the Common Stock S-1).
10.11             Stockholders and Registration Rights Agreement, dated as of
                  June 18, 1997, among the Company, DLJMB Funding II, Inc., DLJ
                  Merchant Banking Partners II, L.P., DLJ Diversified Partners,
                  L.P., DLJ First ESC L.L.C., DLJ Offshore Partners, II, C.V.,
                  DLJ EAB Partners, L.P., UK Investment Plan 1997 Partners,
                  Bankers Trust New York Corporation, Conac & Co., Muico & Co.,
                  Roton & Co. , Putnam high Yield Trust, PaineWebber Managed
                  Investment Trust on behalf of PaineWebber High Income Fund,
                  USL Capital Corporation, Pearlman Family Partners, The Marion
                  Trust, Bruce L. Weitz, BCIP Associates, BCIP Trust
                  Associates, L.P., Tyler Capital fund L.P., Tyler
                  International, L.P.-II, and Tyler Massachusetts, L.P.
                  (incorporated by reference to Exhibit 10.13 to the Common
                  Stock S-1).

                               46           
<PAGE>
EXHIBIT NO.                             DESCRIPTION 
- -----------                             ----------- 
10.12*            Credit Agreement, dated as of February 13, 1998, among Duane
                  Reade, as the Borrower, Duane Reade Inc. and DRI I Inc., as
                  the Parent Guarantors, Various Financial Institutions set
                  forth therein, as the Lenders, DLJ Capital Funding, Inc., as
                  the Syndication Agent for the Lenders, Fleet National Bank,
                  as the Administrative Agent for the Lenders and Credit
                  Lyonnais New York Branch, as the Documentation Agent for the
                  Lenders.
10.13*            Partnership Security Agreement, dated as of February 13,
                  1998, among Duane Reade Inc. and DRI I Inc. and Fleet
                  National Bank, as Administrative Agent.
10.14*            Borrower Security Agreement, dated as of February 13, 1998
                  between Duane Reade and Fleet National Bank as Administrative
                  Agent.
10.15*            Holdings Pledge Agreement, dated as of February 13, 1997,
                  among Duane Reade Inc. and Fleet National Bank, as
                  Administrative Agent.
10.16             Form of Irrevocable Trust Agreement with respect to Senior
                  Notes and Zero Coupon Notes between the Company and State
                  Street Bank and Trust, as trustee.
21.1              Subsidiaries of the Company (incorporated by reference to
                  Exhibit 3.1(i) to the Common Stock S-1).
27.1*             Financial Data Schedule.

- ------------ 
*       Filed herewith. 

    (b)  Reports on Form 8-K.  None. 

    (c)  Financial Statement Schedule: None. 

   Schedules for which provision is made in the applicable accounting 
regulations of the Commission are either not required under the related 
instructions, are in applicable or not material, or the information called 
for thereby is otherwise included in the financial statements and therefore 
has been omitted. 

                               47           
<PAGE>
                                  SIGNATURES 

   Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized. 

Dated: March 27, 1998 

                                          DUANE READE INC. 
                                          (Registrant) 

                                          By: /s/ William J. Tennant 
                                              ------------------------------- 
                                              Name: William J. Tennant 
                                              Title: Chief Financial Officer 

   Pursuant to the requirements of the Securities Exchange Act of 1934, this 
report has been signed below by the following persons on behalf of the 
registrant in the capacities indicated on March 27, 1998: 

<TABLE>
<CAPTION>
         SIGNATURES                                     TITLES 
- ---------------------------  ---------------------------------------------------------- 
<S>                          <C>
/s/ Anthony J. Cuti 
- ---------------------------  President and Chief Executive Officer and Director
Anthony J. Cuti                 (Principal Executive Officer) 

/s/ William J. Tennant 
- ---------------------------  Senior Vice President, Chief Financial Officer (Principal
William J. Tennant              Financial Officer; Principal Accounting Officer )

/s/ Nicole S. Arnaboldi 
- ---------------------------
Nicole S. Arnaboldi          Director

/s/ David L. Jaffe 
- --------------------------- 
David L. Jaffe               Director 


- --------------------------- 
David W. Johnson             Director 

/s/ Andrew J. Nathanson 
- --------------------------- 
Andrew J. Nathanson          Director 


- --------------------------- 
Kevin Roberg                 Director 
</TABLE>

                               48           
<PAGE>
                                  SIGNATURES 

   Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized on       . 

Dated: March 27, 1998 

                                          DRI Inc., 

                                          By: /s/ William J. Tennant 
                                              ------------------------------- 
                                              Name: William J. Tennant 
                                              Title: Chief Financial Officer 

   Pursuant to the requirements of the Securities Exchange Act of 1934, this 
report has been signed on March 27, 1998 by: 

<TABLE>
<CAPTION>
         SIGNATURES                                     TITLES 
- ---------------------------  ------------------------------------------------------------ 
<S>                          <C>
/s/ Anthony J. Cuti 
- ---------------------------   President and Chief Executive Officer and Director
Anthony J. Cuti                  (Principal Executive Officer) 

/s/ William J. Tennant 
- ---------------------------   Senior Vice President, Chief Financial Officer (Principal
William J. Tennant               Financial Officer; Principal Accounting Officer )

/s/ Nicole S. Arnaboldi 
- ---------------------------
Nicole S. Arnaboldi           Director

/s/ David L. Jaffe 
- ---------------------------
David L. Jaffe                Director

/s/ Andrew J. Nathanson 
- ---------------------------   Director 
Andrew J. Nathanson 
</TABLE>

                               49           
<PAGE>
                                  SIGNATURES 

   Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized. 

Dated: March 27, 1998 

                                         DUANE READE INC., 

<TABLE>
<CAPTION>
<S>                                        <C>
By: DRI I Inc., a general partner        By: Duane Reade Inc., a general partner 


By: /s/ William J. Tennant               By: /s/ William J. Tennant 
- ---------------------------------------- ---------------------------------------------- 
        Name:  William J. Tennant                Name:  William J. Tennant 
        Title: Senior Vice President and         Title: Senior Vice President and Chief 
               Chief Financial Officer                  Financial Officer 
</TABLE>

   Pursuant to the requirements of the Securities Exchange Act of 1934, this 
report has been signed below on March 27, 1998 by the following persons in th 
ecapacities indicated with respect to Duane Reade Inc. and DRI I Inc., the 
general partners of Duane Reade, on behalf of Duane Reade: 

<TABLE>
<CAPTION>
         SIGNATURES                                     TITLES 
- ---------------------------  ------------------------------------------------------------ 
<S>                          <C>
/s/ Anthony J. Cuti 
- ---------------------------   President and Chief Executive Officer and Director
Anthony J. Cuti                  (principal executive officer) 
/s/ William J. Tennant 
- ---------------------------   Senior Vice President, Chief Financial Officer (principal
William J. Tennant               accounting and financial officer) 
/s/ Nicole S. Arnaboldi 
- --------------------------- 
Nicole S. Arnaboldi           Director 
/s/ David L. Jaffe 
- --------------------------- 
David L. Jaffe                Director 

- --------------------------- 
David W. Johnson              Director* 
/s/ Andrew J. Nathanson 
- --------------------------- 
Andrew J. Nathanson           Director 

- --------------------------- 
Kevin Roberg                  Director* 
</TABLE>

- ------------ 
*     Duane Read Inc. only 

                               50           



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission